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Growth rates during adolescence are second only to that 
during fetal development and early infancy. Yet information 
on which recommended nutrient intakes are based stems from 
isolated studies with few subjects. Little information 
exists concerning the relationships between growth, 
maturation, and blood lipids which may affect cardiovascular 
health later in life. Likewise, only a few studies have 
been conducted which investigated healthy adolescents and 
mineral status. 
Significance of the Problem 
In 1986 the United States Department of Agriculture 
(USDA) reported to Congress a comprehensive plan for human 
nutrition research (1). Included in this plan was increased 
information on nutritional requirements for adolescents. A 
special need for knowledge about trace mineral needs in 
adolescent males was stated due to their rapid growth rate. 
While USDA emphasized lipids in aging as another 
concern for nutrition research, the concern for 
cardiovascular health also existed for adolescents. If 
there were a relationship between blood lipids in 
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adolescents and lipid levels in these individuals as they 
aged, then those at risk needed to be identified early. 
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Mineral interactions are known to exist. For example, 
iron and zinc competition was identified in several studies 
and clearly demonstrated by Solomons (2,3). Copper and zinc 
may also compete for absorption and/or utilization. Since 
these minerals may affect lipid metabolism, it seemed 
important to investigate plasma lipids in respect to 
maturation and trace minerals. 
The essentiality of zinc for animals was demonstrated 
in the rat in 1934 (4). Essentiality has since been 
confirmed in many other species. However, due to the wide 
distribution of the element, zinc was not considered likely 
to be lacking in the diet of humans. Nevertheless, zinc 
deficiency was first suspected in humans in Iran in 1961 
(5). This deficiency was later confirmed in controlled 
studies in Egypt (6,7). These severe zinc deficiencies were 
characterized by dwarfism, severe anemia, hypogonadism, · 
hepatosplenomegaly, mental lethargy and geophagia. The 
initial studies of zinc deficiency in Iran and Egypt 
included only male subjects; however, zinc deficiency was 
later discovered in females as well (8). It is possible, 
however, that males are more subject to zinc deficiency than 
females since zinc seems to be preferentially sequestered in 
the male genital tract while it is not in the female genital 
tract. In addition studies in other parts of the world have 
shown that indices suggestive of possible zinc deficiency 
are more common in male children than in female (9-11). 
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Zinc is known to be required for DNA and RNA synthesis 
and, thus, is involved in growth. Since little has been 
reported on zinc status in adolescent males, there is a need 
to determine not only zinc status but also maturation and 
growth in this age group. There is no single biochemical 
measure of zinc status which is currently accepted as 
indicative of body stores. Nevertheless, plasma zinc is 
commonly reported by those researching zinc status and 
mineral interactions. Therefore, there is a need to 
investigate the relationships between growth, maturation and 
plasma zinc. 
This study described the nutritional status of 
adolescent males with emphasis on plasma zinc and indicators 
of maturation and growth. Plasma cholesterol and hemoglobin· 
levels were examined in relationship to growth, maturation 
and plasma zinc. Special emphasis was given to identifying 
markers of maturation status and to relationships between 
anthropometric measurements and maturation status. 
Objectives 
The following research objectives were developed for 
the proposed study: 
1. to determine the nutritional status of adolescent 
males based on age; 
2. to determine the growth achievement of adolescent 
males in relation to maturation status; 
3. to determine the relationship between plasma zinc 
and measures of maturation; 
4. to determine the relationship between maturation 
and plasma lipids; and 
5. to determine the relationship between zinc intakes 




The following hyp~theses were developed for this study: 
1. there will be no statistically significant 
differences by age in nutritional status measures 
among healthy male adolescents; 
2. there will be no statistically significant 
differences in growth measures relative to 
maturational status among healthy male adolescents; 
3. there will be no statistically significant 
differences in plasma zinc based on maturation 
among healthy male adolescents; 
4. there will be no statistically significant 
differences in plasma lipids based on maturation 
among healthy male adolescents; and 
5. there will be no statistically significant 
relationship between dietary zinc and measures of 
plasma zinc, growth, maturation and plasma lipids 
among healthy male adolescents. 
Limitations 
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This study is not generalizable since the subjects were 
volunteers, males only, and restricted in geographical area. 
The number of subjects was a further limitation based on 
time constraints of the researcher and economic factors. 
Measurement of plasma zinc was limited by available 
methodology. 
Definitions 
The following terms were defined for the purposes of 
this study: 
1. Dehydroepiandrosterone sulfate - an adrenal 
androgenic hormone which has been shown to increase 
progressively with age and maturation and which has 
little diurnal variation. 
2. Anthropometric measurements - physical measurements 
of the body. In this study these include height, 
weight, midarm circumference, and triceps 
skinfolds. 
3. Health - freedom from disease both acute and 
chronic. 
4. Geophagia - the practice of eating clay. 
CHAPTER II 
REVIEW OF LITERATURE 
This chapter includes a brief review of nutritional 
assessment methodology focusing on the adolescent. 
Nutritional needs for maturation and growth are discussed. 
Zinc, a mineral known to be essential for maturation, is 
emphasized. A secondary emphasis is the status of blood 
lipids in adolescents related to growth and maturation. 
This concern existed due to possible relationships to 
cardiovascular disease later in life. A brief review of 
dietary intake methodology is included. 
Measures of Nutritional Status 
Nutritional status assessment in the complete sense 
includes measures of all factors which may affect the 
biological functioning of the individual. These measures 
would necessarily include anthropometric measures of growth 
and body composition, clinical examination for overt signs 
of nutritional deficiency or excess, biochemical measures of 
the nutrient or nutrients of concern, as well as measures of 
food consumption. Only in studies in which several 
investigators are collaborating can all of these components 
of nutritional assessment be undertaken due to time, 
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expertise and financial limitations. Thus, in each study 
some portions may not be addressed. 
Adolescence is a time of many physiological changes. 
Hormonal changes occur affecting growth and development. 
These changes are not instantaneous nor do they occur at a 
uniform time in all individuals. Therefore, in assessing 
individuals during adolescence, maturation must also be 
considered. 
Growth in Adolescence 
During adolescence growth rates for height vary 
greatly. Therefore, using growth curves not associated with 
maturation status can classify youth incorrectly. Growth 
curves have been developed for North American children which 
not only consider those with average maturation rates but 
also those in whom maturation occurs early or late (12). 
For males these growth and height velocity charts were based 
on typical growth of individuals from 11 to 19 years. Erior 
to age eleven National Center for Health Statistics (NCHS) 
values were used. Data were grafted from NCHS values for 
prepubertal height, height at adulthood, and height at peak 
height velocity to the slope and height of the typical 
adolescent male. Rather than use previously published curve 
fitted data, these values were based on those empirically 
derived. The peak height velocity charts were useful in 
longitudinal studies and for clinicians but did not provide 
information on maturation without accurate height 
measurement from previous years. Tanner maturation 
standards (described in Appendix A) were used in these 
charts so that those individuals at the 97 centile for 
height are "early maturers" and those below the third 
centile are "late maturers. 11 
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Baumgartner et al. (13) developed incremental growth 
tables based on longitudinal data from the Fels Research 
Institute. The sample size was small and localized 
consisting of approximately 818 subjects in southwestern 
Ohio. They produced tables from age six-months in intervals 
of six months for weight and stature increases without 
assessment of maturation status. Values were given for 
growth rates based on percentiles and + 1 or 2 standard 
deviations of the mean. These data were useful in the 
clinical context for determining satisfactory growth rates 
during childhood. They did not provide information on 
actual heights by percentiles. 
Growth and Puberty 
Mills et al. (14) studied the nutritional status and 
growth of 78 boys from age 6 months to 14 years. Both three 
day food records and anthropometric measures were taken at 
ages 1, 3, 6, 9, 12, and 14 years. Stage of puberty at age 
14 was not related to intake of any dietary factor at any 
age. However, those with more developed maturation as 
measured by Tanner stages were heavier as early as age six 
months than those who matured later. At many ages skinfolds 
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were also positively related to more advanced maturation, 
but significance of the relationship existed at only a few 
points. Muscle mass development as estimated by calculation 
of cross-sectional muscle area in seven of the nine time 
periods was also significantly related to timing of puberty. 
Weight was a better predictor of pubertal stage than was 
height. In this study muscle mass was the strongest 
predictor of pubescence. These researchers hypothesized, 
because early weight, lean body mass, and pubic hair 
development were particularly strongly related, that an 
adrenal hormonal factor might be responsible for the timing 
of puberty. 
Wilson et al. (15) also developed growth curves for 
adolescents based on data collected during the third cycle 
of the Health Examination Survey (1966-1967). These curves 
used actual heights attained, age and a sexual maturity 
index (SMI) to set the pattern of curves for those maturing 
at average times. For a clinician or researcher to use the 
curves, however, both pubic hair and genital development 
must be assessed. These curves could then be used to 
predict adult height. 
Body Composition 
Cronk and Roche (16) developed race and sex-specific 
reference values for triceps and subscapular skinf olds and 
weight/stature for both males and females from ages 6 to 
50.9 years. The data for these references were derived from 
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the first National Health and Nutrition Examination Survey 
(NHANES-I). Using these data, the researchers concluded 
that the best single predictor of percent body fatness for 
males ages 6 to 18 was subscapular skinfolds. Nevertheless, 
these researchers recommended that in boys for whom there is 
need to know body fatness both triceps and subscapular 
fatfolds be measured and the weight/stature squared (W/S2) 
should be calculated as well. 
Siervogel et al. (17) compared data from the Denver 
Growth Study and the Melbourne Growth Study to determine 
which measurements were the best predictors of body fatness. 
The Denver data consisted of skinf old measurements from 10 
body sites as well as radiographically determined 
subcutaneous fat while the Melbourne data had only skinf old 
values. Both of these were serial studies so that values 
for the same child might appear in more than one age group. 
These researchers found that abdominal and triceps skinf olds 
predicted body fat to approximately the same degree in · 
prepubertal males. Prepubertal age was arbitrarily defined 
as 4 - 12 years. In the pubertal males, defined as ages 13 
- 16, pectoral and triceps skinfolds predicted body fatness 
to the same degree. Thus, in males through age 16 triceps 
were a satisfactory, accessible and easily measured skinfold 
which predicted body fatness with a correlation from r=0.69 
to r=0.79. 
When the correlations of each site were calculated with 
each other site, Siervogel and colleagues (17) found that 
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site to site variation was great during the prepubertal 
years in both sexes. However, as the individual approached 
puberty the subcutaneous fat layers tended to become more 
evenly distributed. That is, if the skinfold thickness were 
small at one site the tendency was to be small at all sites. 
This similarity of fat thickness throughout the body tended 
to disappear after puberty and into the mid-twenties. 
In analyzing to determine the relationship between body 
fatness and the available anthropometric measures, Siervogel 
and coworkers (17) found that the skinfolds were strongly 
correlated to weight but were more strongly related to W/s2 . 
There were no significant correlations between skinfolds and 
height. Based on their data from Denver and Melbourne, 
these researchers stated that triceps was the single best 
measurement site in boys through age 16. They cautioned 
that age and gender should be considered when selecting a 
site to be representative of body fatness. 
Frishancho (18) also used NHANES-I data to determine 
norms for upper limb fat and muscle areas. Tables were 
developed using data from white subjects only. These norms 
do not represent the values that could be classified as 
desirable, but rather these values were the means and 
distributions of values found in the national probability 
sample. These values indicated that with increasing age the 
increase in upper arm fat was more clearly shown when fat 
was expressed as fat area rather than skinfold thickness. 
Frisancho suggested that both triceps and arm circumference 
measures be converted into fat area and muscle area for a 
more adequate description of an individual's energy and 
protein reserves. 
Hemoglobin in Adolescents 
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Although growth curves have been developed for heights 
and weights of children for some time, Dallman and Siimes 
(19) recently developed percentile curves for hemoglobin 
levels in white infants and children from samples totaling 
2314 children collected in the United States (3 groups) and 
Finland (2 groups). All these children lived near sea level 
and in all but one group additional hematological data were 
collected to eliminate children with evidence of iron 
deficiency, thalassemia minor and/or hemoglobinopathy. The 
curves include the third, fiftieth, and ninety-seventh 
percentiles of non-indigent subjects from birth through age 
sixteen. Tabular data were also presented on the median 
(SOth percentile) and lower limits (3rd percentile) by age 
and gender groups. These curves and table showed a gradual 
increase in hemoglobin concentration throughout childhood. 
Daniel (20) has reported changes in hematocrit percent 
related to pubertal changes. The subjects were adolescents 
11 to 20 years from low income families. Hematocrit was 
related to Tanner sexual maturity staging but not to 
chronological age in males. This relationship was not found 
in females. After maturation stage two a significant 
increase in hematocrit occurred which remained linear 
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throughout the ages studied. For black males the slope 
remained lower throughout the maturity stages covered and 
did not have the flat portion found in whites between stages 
one and two. 
Iron nutriture data from NHANES-II were summarized by 
an expert group from the Life Sciences Research Off ice of 
FASEB (21). The conclusion reached from these analyses was 
that· there currently was no single indicator which was 
diagnostic of iron deficiency. However, they found evidence 
of changes in iron status indicators based on age 
particularly in infancy, childhood and adolescence. Several 
models using biochemical indicators of tissue iron were 
developed to predict iron status. 
This group also compared the association between low 
hemoglobin concentration and abnormal values for the various 
iron status indicators in whites. They found an increase in 
occurrence of low hemoglobin values in individuals 
identified as having abnormal serum ferritin, mean 
corpuscular volume, transferrin saturation and erythrocyte 
protoporphyrin. The three iron status models developed 
required two of three indicator values to be abnormal before 
identification of the individual as iron deficient. When 
comparing those identified by the iron status models, they 
found few individuals had a severe enough deficiency to be 
reflected in low hemoglobin concentrations. Thus hemoglobin 
alone missed those individuals with marginal deficiency or 
inadequate stores of iron. 
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Conclusions concerning the iron status of the healthy 
non-institutionalized population in the United States 
included that males aged 11 to 14 years had a high 
prevalence of iron deficiency indicators compared to all 
other age and gender groups including females of the same 
ages. They also concluded that there were discrepancies for 
all three of the models in estimating the prevalence of iron 
deficiency. In adolescent males occurrence of iron 
deficiency was predicted to range from 3.5% to 12.1% 
depending on the model used. This variation between models 
supported the need for more than one biochemical indicator 
for defining iron status of individuals or populations. 
There are changes in adolescence that affect need for 
dietary iron which if unmet may result in iron deficiency. 
Dallman (22) reported in a review article that, in order to 
maintain a constant hemoglobin concentration, male 
adolescents must increase their net body iron level by 
300 mg in the year of peak growth. Additional iron was 
reported to be necessary because the concentration of 
hemoglobin also increases between 5 and 10 g/L during these 
years. 
Others have reported increased hemoglobin levels during 
the adolescent years. Seoane et al. (23) studied 
hemoglobin, hematocrit, and serum ferritin levels in 574 
Canadian adolescents 10 to 18 years old related to dietary 
iron intake from three day food records. No abnormal 
hemoglobin or hematocrit values were found. The group (two 
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year age interval groups) means for serum ferritin were all 
within the normal levels but were low. The hemoglobin 
concentration increased significantly (p<0.01) from ages 10 
to 18 years in males. No relationship was found between 
dietary iron intakes and hemoglobin levels. The low serum 
ferritin concentrations suggest that iron deficiency existed 
in the adolescents, but this was not discussed. 
As part of the Bogalusa Heart Study, Nicklas et al. 
(24) examined hemoglobin concentration and erythropoietic 
nutrients in adolescents and preadolescents in a racially 
mixed community. Duplicate 24 hour dietary recall records 
were used to assess the nutrient intakes of these children. 
They found higher hemoglobin concentrations in males 15 
years old than in 10 year old males. Using regression 
analysis they found that individual dietary components (heme 
iron, non-heme iron, copper, zinc, folacin, and vitamins c, 
B6, Bi2 1 and E) contributed little to the prediction of 
hemoglobin levels. 
Looker et al. (25) examined dietary intakes and iron 
status indicators of vitamin-mineral supplement users and 
nonusers in individuals 1 - 19 years. The data source was 
NHANES-II. Only individuals using supplements daily were 
classified as users; nonusers were individuals never using 
supplements. Occasional users were excluded from the data 
subset. Data did not include the amount of iron in the 
supplements. No significant differences were found between 
users and nonusers for hemoglobin, mean corpuscular volume, 
erythrocyte protoporphrin, or transf errin saturation in 
males 11 - 19 years. They also reported few dietary 
differences between users and non users. 
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From these reports it seemed that adolescent males may 
be a commonly overlooked group for insufficiency of iron 
intake. There appeared to be increases in hemoglobin 
concentration occurring with puberty and little relationship 
of reported nutrient or supplement intakes and measures of 
iron status. 
Hormonal Changes and Puberty 
Physiological changes occur in maturation before the 
actual occurrence of puberty. Among these changes are 
increases in secretion of adrenal hormones. This period is 
defined as adrenarche. While. the adrenals secrete several 
hormones, dehydroepiandrosterone (DHA) and dehydroepiandros-
terone sulfate (DHEAS) have been described as the most 
useful markers because the adrenals account for over 90% of 
the adult plasma levels of these hormones (26). The 
increase in DHEAS is seen as early as age 7, much earlier 
than increases in gonadal hormones. 
Katz et al. (27) examined 208 Black adolescent males 
who were participating in the Philadelphia Blood Pressure 
Project. There were 5 age groups nearly evenly divided from 
age 12 to 16. They tested the hypothesis that earlier 
maturation was associated with increased adrenal androgens 
(measured only as DHEAS) independent of gonadal maturation 
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(measured by testosterone level). They found that levels of 
DHEAS were consistently associated with adiposity regardless 
of stage of gonadal maturation. A consistent and 
significant pattern of increased DHEAS was associated with 
an increased level of adiposity throughout adolescence. A 
significant relationship was also found between DHEAS and 
bone age. They concluded that a prepubertal increase in 
DHEAS accompanied by excess adiposity were associated with 
earlier onset of sexual maturation. 
Katz et al. (28) also examined the relationship between 
levels of DHEAS and blood pressure as part of the 
Philadelphia Blood Pressure Project. When the subjects were 
grouped into tertiles of DHEAS by each age group, the high 
DHEAS groups (DHEAS concentration greater than one standard 
deviation above the mean concentration for each age) were 
found to be significantly different from the lower two 
tertiles in skeletal age, weight, height, and W/s2 . There 
was no difference in blood pressure based on DHEAS level in 
males. Blood pressure variations in males were associated 
with the interaction of W/s2 and serum DHEAS. 
Lee and Migeon (29) conducted a longitudinal study 
correlating the concentrations of eight steroid hormones in 
males with other physiological events associated with 
puberty, including age. In the group of subjects were 11 
boys who had no signs of puberty as well as 43 ?oys in 
various stages of puberty. Physical examinations and serum 
studies were conducted at intervals of six months. Data 
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from the boys followed throughout puberty showed that DHEAS 
rose only after Tanner's stage one of sexual maturation both 
for genital and pubic hair staging and that significant 
changes in DHEAS concentration occurred between stage one 
and two. These changes occurred when DHEAS rose from 500 to 
750 ng/mL (1.3 - 2.0 umol/L). Comparisons of the pubertal 
events of genital development and appearance of pubic and 
axil.lary hair with the various hormones studied showed that 
DHEAS levels increased with the appearance of both axillary 
hair and growth of the genitals. In this study, the 
increase in serum concentration of DHEAS was associated with 
the onset of puberty. 
Hopper and Yen (30) also studied concentrations of 
DHEAS during puberty. Their data showed a rise in DHEAS 
levels in males beginning at age eight with a two-fold 
increase in the level between eight and adulthood. However, 
their data do not include any observations of development of 
secondary sex characteristics. 
Babalola and Ellis (31) developed reference charts for 
serum DHEAS in a normal pediatric population. They used 274 
children between the ages of 1 month to 18.7 years who were 
hospitalized for minor surgery. Of these 274 children 131 
were males. Only those who were clinically normal were 
included in the study. From the patients' records, Tanner 
pubertal staging was determined when possible. The data 
were presented in figures which were estimated to include 
95% of the population. There was wide variation in serum 
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levels of DHEAS in all of the Tanner stages, but there was 
no overlap between Tanner stage one and two or between stage 
three and four in mean values and one standard error of the 
mean. Considerable variation was seen not only with 
maturation but also with chronological age; values <3 umol/L 
were seen in children 8 - 9 years of age and were considered 
normal. However, during the prepuberty years of 10 - 12 
values of <6 umol/L were listed as normal. Furthermore, 
between the ages of 13 to 16 normal ranges were 3 - 13 
umol/L. Apparently, variation occurred in maturation and 
chronological age as identified by the adrenal androgen 
DHEAS. 
Forti et al. (32) studied the peripheral and testicular 
levels of testosterone and DHEAS in 29 boys being treated 
for undescended testis, inguinal hernia, or variciole. Of 
these, 18 were determined to be prepubertal. The subjects 
were grouped into two groups either prepubertal (Tanner 
stage 1) or pubertal (Tanner stage 2-4). Significant 
differences were found between the two groups for DHEAS but 
no differences were seen within groups for spermatic or 
peripheral levels of either hormone. Testosterone levels 
were significantly higher in spermatic serum than in 
peripheral in both groups with the levels being 
significantly higher in the pubertal group than in the 
prepubertal group. There was no relationship between 
spermatic testosterone and DHEAS in either group. Their 
data neither supported nor ruled out the possibility of 
testicular production of DHEAS. 
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Reiter et al. (33) studied secretion of DHEAS from -
infancy through adolescence. Preadolescent children were 
grouped into 2-year chronological age intervals. DHEAS 
levels rose significantly within the 8-10 age group and the 
10-12 age group and again for the 12-14 age group. A 
significant increase was again found for the 14-16 age 
group. When the data were evaluated according to skeletal 
maturation, the same distinctions were found. This group 
did not find significant differences between males and 
females for DHEAS although the mean values for males tended 
to be higher after age 10 than those values in females. 
This study included children with precocious adrenarche; the 
levels of DHEAS found in these children compared with the 
normal children support the hypothesis that DHEAS was 
involved in initiating the growth of pubic and axillary 
hair. In the patients with chronic adrenocorticotrophic 
hormone (ACTH) deficiency, there was no observable secretion 
of DHEAS. When ACTH was administered in pharmacologic 
doses, DHEAS levels reached normal prepubertal and pubertal 
levels within four hours. These results supported the 
hypothesis that secretion of DHEAS is influenced by ACTH. 
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Hormone Status and Measures of Zinc Status 
Severe zinc deficiency is known to cause delayed sexual 
maturation, however, the effects of marginal deprivation 
during the adolescent growth spurt are not known. Golub et 
al. (34) used Rhesus monkeys as a model to study mild zinc 
deprivation during adolescence because these monkeys show 
similarities with humans in regard to the adolescent growth 
spurt and to the physiological changes surrounding it. Ten 
male monkeys from dams fed either zinc deficient or control 
diets from conception to weaning were evaluated for growth, 
sexual maturation, testosterone level, food intake, plasma 
zinc and red cell zinc as well as presence of signs of more 
severe zinc deficiency such as alopecia and dermatitis. 
Between weaning and adolescence these monkeys were fed ad 
libitum either a zinc deficient or control diet. At 30 
months and continuing until 42 months the animals were pair 
fed with the amount of diet supplied to controls based on 
the amount consumed by the experimental· animals. Diets were 
formulated to contain 4 mg Zn/kg for the experimental group 
and 100 mg/kg for the controls. The effects of zinc 
deficiency on growth were significant delays in onset of 
weight gain and sitting height and decrease in subcutaneous 
fat. Sexual maturation did not differ in the groups although 
there was great individual variation. Sexual maturation in 
monkeys is thought to occur between four and five years and 
did not occur in this group by the end of the study at 42 
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months. Plasma zinc levels were significantly lower in the 
test group at the beginning of the study than in the 
controls, but by the end of the study decreases had occurred 
in the control group leading to no significant differences 
in the groups at 42 months. Red blood cell zinc declined 
about 30% in both groups between months 30 and 36 leading to 
a significantly greater decline in the experimental group 
from ages 33 to 42 months. Because the animals were pair 
fed, differences that might occur due to amount of food 
consumed were eliminated. As has been documented elsewhere, 
plasma zinc levels tended to decline as the growth spurt 
progressed. 
Castro-Magana et al. (35) studied serum zinc and 
response to methyltestosterone administration in 369 boys 
with constitutional growth delay or familial short stature. 
Before treatment with methyltestosterone subjects with 
constitutional growth delay had significantly lower serum 
zinc levels than those boys with familial short stature. 
After treatment serum and hair zinc levels increased; the 
increase in those with constitutional growth delay was 
highly significant (p<0.001). 
When Collipp et al. (36) subsequently treated two 
children, who were deficient in growth hormone and who had 
low hair zinc concentrations, with zinc supplements, both 
children had significant increases in growth which persisted 
at least two years. The zinc doses consisted of 220 mg 
znso4 per day for two years. No growth hormone was given, 
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but after the oral zinc treatment the hormone levels were 
normal. While this report was based on only two children, 
one male and one female, it suggested the need for 
investigation of zinc status in growth deficient children 
before further treatment. 
This research team also treated a group of children 
between the ages of 7 and 13 who had low hair zinc and short 
stature but no other apparent abnormality (37). All had 
been of normal birth weight but present bone age was at 
least 2 years less than their chronological age. One group 
was treated with 50 mg of elemental zinc per day for two 
months followed by 50 mg per week for ten months. The other 
group received 100 mg of elemental zinc daily for one year. 
No reference was made to verification of compliance. 
Following treatment the children were again divided into two 
groups--those who grew more than 6 cm/yr and those who grew 
less than 6 cm/yr. The children who grew more than 6 cm/yr 
had significant increases in hair, serum, and urine zinc 
within 2 months of treatment while those who grew less did 
not. In both groups of children hormone levels of serum 
testosterone, somatomedin c and growth hormone at insulin 
peak increased following zinc supplementation. There was a 
different response in children who took the two different 
size doses of zinc; those taking the 50 mg dose grew less 
and had lower hair zinc levels than those receiving the 100 
mg dose. In addition, the high zinc dose group also had 
lower serum copper levels after treatment than did those 
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receiving the 50 mg zinc dose. While no overt signs of 
copper deficiency were observed, the report did not extend 
beyond the one year supplementation trial. Again, 
interrelationships between hormones involved in growth and 
zinc were shown; the mechanisms for those interrelationships 
were not revealed. 
Cheruvanky et al. (38) reported the results of an 
intervention trial in children with growth hormone 
deficiency treated with zinc supplements. They compared 
hair, serum, and urinary zinc with growth rate. These 
children were treated with growth hormone for three months 
with no zinc supplements followed by the hormone therapy 
with the addition of 50 mg zinc per day. Hormone treatment 
alone increased hair zinc levels and decreased urinary zinc 
significantly but there was no significant change in serum 
zinc. Zinc administration in addition to the hormone 
therapy significantly increased growth velocity over the 
velocity from hormone therapy alone. No report of effect of 
supplemental zinc on serum zinc was given. These 
researchers concluded that androgens were involved in the 
metabolism of zinc and that the effect of these anabolic 
hormones was mediated through their action on zinc 
metabolism. 
Zinc Deficiency in Children 
Zinc deficiency and marginal zinc deficiency have been 
reported both in the United States and in other countries. 
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Classical studies eliciting the characteristics of zinc 
deficiency originated in the Middle East. The first such 
report was from the Nemazee Hospital in Iran (5). Prasad et 
al. reported what appeared to be undernourished 
males with no sign of intestinal parasites nor blood loss 
whose symptoms included severe iron deficiency anemia, 
hepatosplenomegaly, short stature and hypogonadism. Iron 
supplements corrected the anemia and decreased the liver 
enlargement; this treatment also resulted in beginning of 
development of the genitalia. The common characteristics of 
the eleven subjects' diets were that they consisted 
primarily of unleavened wheat bread with little meat or 
dairy products and fruits and vegetables occasionally in the 
growing season. The diets were notably deficient in animal 
protein. Geophagia o.f long duration was noted in all but 
one subject; that subject may also have consumed clay but 
was not asked. Serum zinc was determined in only one 
subject; the value was low--71 ug/dL. While zinc deficrency 
was not confirmed in this early study, it was hypothesized 
to be the factor responsible for the symptoms. 
In 1963 Prasad et al. (6) published a report on further 
studies on males with the syndrome of hepatosplenomegaly, 
anemia, dwarfism and hypogonadism. The subjects for this 
report were from villages near Cairo, Egypt. Biochemical 
tests led to the conclusion that these subjects were zinc 
deficient. This group was not treated with zinc supplements 
to confirm the diagnosis. 
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In Iran, Eminians and colleagues (39) reported a 
syndrome similar to nutritional dwarfism with other 
associated symptoms of anemia, hepatosplenomegaly, and 
growth retardation. The purpose of this study was to seek 
preadolescent children who had the hypothesized symptoms of 
zinc deficiency. Hospitalized youth with the symptoms of 
anemia, hepatomegaly, splenomegaly or growth retardation not 
explained by other diseases comprised the sample. 
Biochemically, these children had lower plasma zinc, hair 
zinc, and red blood cell zinc than normal subjects in the 
same village and other suburban children. While their 
specific diets were not studied, they were known to contain 
high levels of phytates and fiber which bind zinc. Clinical 
evidence of zinc deficiency was found more often in males 
than in females and more often in village males than urban 
males. 
Zinc deficiency was later confirmed in females by 
Halsted and associates (8). In this study male and female 
patients were randomly assigned to one bf two groups: 
placebo and a nutritious diet or zinc supplemented and the 
good diet. A third group was formed from those receiving 
the placebo by replacing the placebo with the zinc 
supplement after six months of initial treatment and 
continuing the diet. Those who were anemic also received 
an iron supplement, which was tested to be low in zinc, for 
the length of time required to relieve the anemia. 
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The two female subjects who were included had symptoms 
similar to those of the males including sexual immaturity. 
Thus, zinc deficiency is known to affect both males and 
females but seems to be more prevalent in males. 
The good diet and treatment for anemia resulted in slow 
growth increases but no change in sexual immaturity. Within 
six weeks of adding zinc supplements (27 mg elemental zinc) 
overt signs of puberty were present. In addition, growth 
rate markedly increased with the zinc supplements. 
Because zinc is preferentially sequestered in the male 
genital tract but not in the female, it has been suggested 
that either a greater need for or a need for greater 
retention of zinc existed in males. Several studies have 
found signs of overt or marginal zinc deficiency with 
greater frequency in males than in females (9-11,39). 
In the United States marginal zinc deficiency has been 
observed in young children. In 1972 Hambidge et al. (40) 
reported that some apparently normal healthy young children 
had very low levels of zinc in hair (<70 ppm). Nine of 
these ten children also were below the tenth percentile for 
height and/or weight. Five of the six children when tested 
for taste acuity had significantly higher taste thresholds 
than did the controls with hair zinc at normal adult levels 
(>70ppm). Retesting following one to three months of 
treatment with 1-2 mg znso4/kg body weight resulted in 
normal taste acuity and substantial increases in hair zinc 
levels. 
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This first report of suspected zinc deficiency in 
young apparently healthy children in the United states led 
to further investigations in children both in impoverished 
and middle income families. In the mid 1970's Hambidge et 
al. (41} selected children enrolled in a Head Start program 
who were below the tenth percentile on Iowa Growth Grids. 
Hair and plasma were analyzed for zinc and compared with 
children from middle income homes attending a private 
preschool. The subjects were not fasting when blood was 
drawn but were at least 2 hours postprandial. Plasma zinc 
was low (<68 ug/dL} in about one third of the Head Start 
subjects but only low in 3.8% of the middle income children. 
No supplementation studies were done with these children, 
but the authors concluded that poor zinc nutrition might be 
common in low income children. 
Because low income children, many of whom were of 
Mexican descent, were shown to have symptoms characteristic 
of zinc deficiency, Chase et al. (42) studied the 
relationship between vitamin A and zinc concentrations in 
Mexican-American migrant children who were growth retarded. 
Growth retardation determined as less than the third 
percentile in either height, weight or head circumference 
was the criterion for participation. Fasting blood samples 
were obtained for determination of serum vitamin A and serum 
zinc as well as other biochemical measures. No significant 
correlations were found among serum vitamin A, serum zinc, 
hair zinc or height. However, mean values for serum vitamin 
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A, zinc and hair zinc were lower in the migrant children 
than in the middle income controls from a previous study. A 
later study (11) paired low income Mexican-American 
preschool children for a 12 month zinc supplementation 
study. All subjects and controls were below the tenth 
percentile for height for age. Selection was further 
limited by requiring a dietary intake of <2/3 of the RDA for 
zinc, hair zinc <105 ug/g, or plasma zinc <68 ug/dL. Fifty-
seven subjects were thus initially recruited for the study. 
Experimental subjects received a total of 10 mg zinc per day 
in divided doses while the controls received placebos 
indistinguishable from the zinc supplements. Results showed 
significant increases in height velocity in the experimental 
group primarily as a result of the increases in the males. 
Mean plasma zinc did not increase in the experimental group 
but significant increases in hair zinc were found in both 
the experimental and control groups. There were no 
significant correlations between hair zinc and plasma zinc. 
Because only the male children had significant increases in 
height when given zinc supplements, the possibility of 
higher zinc needs for males than for females was supported. 
Before zinc fortification of infant formulas was a 
common practice, Walravens and Hambidge (9) investigated the 
effect on growth, hair zinc and plasma zinc of a zinc 
fortified formula. The study design was a double blind 
control protocol with the unsupplemented formula containing 
1.8 mg/L zinc and the supplemented formula containing 
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5.8 mg/L. Results were significantly different by six 
months; the supplemented males were significantly longer and 
heavier than the control males. No significant differences 
were found between supplemented and control females. At 
three months both male and female supplemented inf ants had 
significantly higher plasma zinc than the controls, but by 
six months the difference was significant only for male 
infants. ~o significant differences were found between the 
groups in hair zinc concentration during the study. 
Smit Vanderkooy and Gibson (43) recently reported food 
consumption patterns of Canadian preschool children in whom 
zinc and growth status were assessed. Average intakes of 
protein, calcium, iron, and zinc for both males and females 
were above the Canadian Recommended Nutrient Intakes; there 
were significant correlations between dietary zinc and both 
energy and protein intakes. For males only, significant 
correlations were found between hair zinc and height for age 
percentiles; those with hair zinc <70 ug/g were 
significantly shorter than those with hair zinc >70 ug/g. 
Boys with either low hair zinc or retarded growth (group A) 
consumed significantly more calcium than did the other 
males; no differences were seen for energy, protein or any 
other nutrients between these groups. However, the boys in 
group A consumed significantly less meat, fish, and poultry 
and more milk and dairy products and, therefore, consumed 
zinc from different food groups than did those boys with 
either higher hair zinc or greater growth achievement. 
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Gibson et al. (44) later examined the effect of zinc 
supplementation on young boys (mean age 76.7 months) who 
were at or below the 15th percentile for height and whose 
parents were >25th percentile for height. Based on the 
earlier study which showed evidence of zinc deficiency more 
commonly in males, this group documented the suspected zinc 
deficiency in a double-blind pair-matched 12 month study. 
All subjects (ri=60) were Caucasian, apparently healthy, and 
full term with appropriate weight at birth. Subjects were 
tested, measured, and hair and blood samples were taken at 
the beginning, at 6 months and at the 12 month completion. 
All blood samples were obtained from fasting subjects; 
compliance in consuming the 10 mg zinc supplement or placebo 
was monitored at 6-week intervals. Weighed 5 day food 
records were kept at the beginning and end of the study. 
Three day records were kept at midpoint. Vitamin-mineral 
supplements were recorded although parents discontinued the 
use of iron supplements during the study. There were no 
significant differences at 6 months or 12 months between the 
supplemented and placebo groups for any of the measures 
examined: changes in weight for age, height for age, weight 
for height Z scores, taste acuity, hair zinc, serum zinc or 
copper, or ceruloplasmin. When the subjects were grouped 
according to initial hair zinc levels, no differences were 
seen at initial screening except that mean weight of the 
boys with low hair zinc was significantly less than those 
with "normal" hair zinc when height was considered a 
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covariate. No significant differences were seen in dietary 
intakes although those with low hair zinc tended to consume 
less energy nutrients and more calcium and phosphorus. 
Initial mean intakes of calcium, iron, zinc and protein were 
>100% of the Canadian Recommended Nutrient Intakes with the 
exception of calcium in the high hair zinc group. Those 
boys with low hair zinc had significantly higher initial 
mean recognition thresholds for salt than did boys with high 
hair zinc although at the end of the study there were no 
significant changes in median taste thresholds for the low 
or high hair zinc groups according to zinc supplementation. 
By the end of the study boys with initial low hair zinc who 
received the zinc supplement had significantly greater 
changes in height for age Z scores than those boys receiving 
the placebo. Results showed that only boys with low height 
percentiles, low hair zinc and hypogeusia responded 
significantly to the effect of zinc supplementation by 
increases in height for age. 
Hambidge et al. (45) used a zinc fortified breakfast 
cereal to study the effects of zinc supplementation in 93 
middle income children enrolled in a private preschool and 
kindergarten in Denver. A specially formulated zinc 
supplemented breakfast cereal was given to families in the 
experimental group; control group families received cereals 
as well which were unsupplemented. Supplementation was 
sufficient to provide 25% RDA for zinc per one ounce serving 
(3.75 mg zinc as zinc oxide). At the initial assessment 
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boys had significantly higher mean plasma zinc and parotid 
salivary zinc but significantly lower hair zinc than did the 
girls. Changes occurred in both control and experimental 
subjects over the course of the school year for plasma zinc 
and hair zinc, but analysis of changes in experimental 
subjects showed that there were statistically significant 
changes in plasma zinc (girls alone and both sexes) and hair 
zinc· (girls). Children in the experimental group had a 
smaller decline in plasma zinc and a greater increase in 
hair zinc than did the controls. At the end of the study 
period there were no significant differences in plasma zinc 
between zinc supplemented girls and the mean values for 
young adult women in that laboratory. But for males, both 
the supplemented and control boys had significantly lower 
plasma zinc levels than were found in healthy young adult 
males. Mean daily growth increments tended to be greater in 
the supplemented children but not significantly different 
from the controls. The amount of zinc added to the 
children's diets was small averaging only 2.57 mg/day. This 
amount may not have been sufficient to see statistically 
significant differences in the two groups. Growth rates 
tended to be greater in the supplemented group, and had they 
received more zinc the difference might have been 
significant. 
Interestingly, all of these studies in preschool and 
very early elementary children have documented only mild 
zinc deficiency characterized by short stature, low hair 
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zinc levels and in some cases hypogeusia. Questions arise 
concerning the outcome of these children during the rapid 
growth spurt of adolescence had their mild deficiency not . 
been documented and treated. Would these children be those 
who mature late or who continue to be short for age? 
School age children were screened for zinc deficiency 
in several studies in both the United States and other 
countries. Many of these studies found incidences of 
possible and/or definite zinc deficiency (10,46,47). 
Heinersdorff and Taylor (10) examined the growth and 
hair zinc of British children between the ages of 10 and 11 
to document the existence of marginal zinc deficiency in 
British children by standards which had been used 
previously--growth retardation and low hair zinc. Hair zinc 
levels were significantly lower in males than in females 
although only 3.7% of the sample had low hair zinc. 
Fourteen of the 219 participants were below the 10th 
percentile for height and 19 were below this percentile for 
weight, but none of these had hair zinc <90 ug/g. There 
were no statistically significant relationships between hair 
zinc, height, weight, birth rank, socioeconomic status, or 
food consumption practices. No measures of maturation were 
taken and no other biochemical measures were reported. It 
was assumed that this was a healthy population with normal 
zinc status. 
A group of 110 Yugoslavian children between the ages of 
9 and 12 were studied by Buzina et al. (46) for taste acuity 
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and zinc nutritional status. Taste acuity was determined by 
the three drop forced choice method, and zinc status was 
measured by hair and plasma zinc. The results showed that 
children who had greater height for age also had higher 
plasma and hair zinc levels than did the children who were 
shorter for age. Regression analysis revealed significant 
correlations between hair and plasma zinc and relative body 
weight as well as between these biochemical measures and 
upper arm circumference. No significant relationship was 
found between plasma zinc and taste acuity although the 
prevalence of plasma zinc <70 ug/dL was greater in the group 
with hypogeusia. The hypogeusia found in some of these 
children was mild and did not have a significant effect on 
growth; three of the four children who were below 90% of the 
standard of weight for age had moderate to a more severe 
degree of taste dysfunction. 
From these studies of children there appeared to be a 
relationship between growth, taste acuity and zinc status. 
Hair zinc may not be a good measure of zinc status because 
the level is known to change with differences in seasonal 
growth rates. There may also be problems in using absolute 
amounts of plasma zinc as a measure of zinc status during 
growth years. 
Butrimovitz and Purdy (47) reported a study of 
apparently healthy children in the Baltimore, MD, area in 
which non-fasting plasma zinc levels followed a curvilinear 
pattern increasing early in childhood and decreasing during 
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the ages in which one would expect puberty to occur. No 
measures of maturation were taken, however. These declines 
occurred in both females and males although the decline was 
approximately two years earlier in females than in males. 
They suggested that while the decline in males was not 
sharp, the extended growth period of adolescent males was 
reflected in the continual decline of plasma zinc from about 
age 13 to 18. 
In 1985, fasting serum zinc levels were reported for 
youth for whom measures of sexual maturation also existed 
(48). The sample consisted on 205 adolescents between the 
ages of 11 and 19 with 95% between 12 and 16. Sexual 
maturation was determined at the time of clinical visits 
according to Tanner stages. Mean serum zinc for males with 
the adult rating of sexual maturity (stage 5) was 
significantly higher than for the males in all other stages.· 
There were no differences in serum zinc between the other 
four stages in males. No data were collected on growth 
achievement or other measures of zinc status. No 
distinctions could be made between mild deficiency and 
normal physiological changes. 
Biochemical Defects in Zinc Deficiency 
In animals low zinc diets affected growth and appetite 
with such rapidity that these functions decreased before 
general tissue depletion of zinc occurred. Such results 
suggested that the primary site of zinc action was in 
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constituents of tissues with high zinc turnover rates; 
further, the action of zinc must be in those enzymes in 
which the zinc was freely exchangeable between the enzyme 
and the other macromolecules which require zinc for action 
( 49) • 
Studies of tissue homogenates of rats and pigs showed 
that zinc content and RNA to DNA ratios were significantly 
decreased in liver, kidney, pancreas, and bone in zinc 
deficient animals when compared to pair-fed controls (49). 
Tissue homogenates had significantly less protein and RNA 
but not less DNA than did the controls. Specifically, the 
activities of zinc depepdent enzymes in these tissues were 
reduced: alcohol dehydrogenase in liver, kidney, and bone; 
aldolase in liver and kidney, alkaline phosphatase in kidney 
and bone; carboxypeptidase in pancreas; and lactic 
dehydrogenase in bone. Adding zinc to the tissue homogenate 
did not increase enzyme activity which suggested the mineral 
was a structural part of the enzyme or was tightly bound. 
Tissue changes were not observed for the iron dependent 
enzymes in these tissues suggesting that zinc deficiency 
affected only the zinc dependent enzymes. 
It was important to note that activities of zinc 
dependent enzymes needed to be determined on those tissues 
sensitive to zinc depletion (49). Not all zinc dependent 
enzymes were similarly affected due to the varying affinity 
for zinc of these enzymes and to the turnover rate of the 
cells. Prasad et at. (49) reviewed studies by sandstead and 
38 
Rinaldi that suggested a role for zinc in cell division; 
Sandstead and Rinaldi had previously found reduced thymidine 
incorporation in the nuclei of zinc deficient tissues while 
the DNA content of the tissue remained unchanged. 
Tipton et. al.(50) found the tissues in humans with the 
greatest amount of zinc in decreasing order were: retina, 
choriod, prostate, kidney, muscle and bone. The enzymes and 
tissues identified by Prasad et al.(49) as important for 
determining the effects of zinc deficiency were not 
available for human studies. Because these tissues are not 
accessible, routine screening examinations require that 
other tissues be studied. 
Factors Affecting Zinc Homeostasis 
Effects of Phytate and Fiber 
With the typical diets of Middle Eastern subjects known 
to contain large amounts of fiber and phytates, Reinhold 
(51) conducted studies to determine the bioavailability of 
zinc. The effect of phytate on zinc availability was only at 
or near the sites of absorption and was dependent upon the 
pH of the gastrointestinal tract. Calcium was a synergistic 
factor involved as a complexing factor in the precipitation 
of zinc by phytate. When Reinhold and associates added 
leaven to the wholemeal bread, they found the solubility and 
absorption of the zinc present increased. While the 
leavening agent may increase solubility, they believed that 
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a factor other than the phytate was responsible for the poor 
absorption of the abundant zinc in the village bread. 
Later Reinhold and co-workers (51) found that the zinc-
fiber bond in wholemeal bread was in a proportional 
relationship so that as the proportion of zinc increased the 
amount of zinc bound to fiber decreased. They stated the 
binding curve was suggestive of an adsorption relationship. 
Studies of village bread indicated a zinc binding capacity 
of 3 mg/g fiber. Although phytate in wholemeal could be 
degraded, the fiber could not. Therefore, this adsorption 
might be particularly important in zinc deficient subjects 
who consumed large amounts of dietary fiber. 
The binding of zinc by phytate and bran, among other 
substances, was pH dependent. The solubility of zinc was 
low at neutral pH and increased with decreasing pH 
particularly at pH less than 6.0. This solubility-pH 
relationship occurred when zinc hydroxide was mixed with 
various solids indicating that the solubility was a property 
of zinc itself and not a property of gastric contents (51). 
In a controlled study with eight men housed for four to 
eight months and consuming diets similar to those of typical 
middle class American men, Sandstead et al. (52) studied the 
effects of increasing the fiber content of the diet by the 
addition of 26 grams of either soft white wheat bran or 
dried milled corn bran. Net total fiber was more than twice 
as high in the corn bran as in the wheat bran. Neither of 
these fiber sources affected zinc balance in the amounts 
fed. - This study as well as one conducted by Sandstrom et 
al. (53) showed that when fiber was added to the typical 
Western diet no deleterious effects were seen in zinc 
balance. 
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Drews et al. (54) studied the effect of fiber added to 
the diets of adolescent males. Eight subjects participated 
while living at home but consuming only the diet in the 
laboratory. The study was short--only 21 days: two days for 
nitrogen depletion, a three day nitrogen adjustment period 
which was followed by four experimental periods during which 
a basal diet was fed or basal plus 14.2 grams of 
hemicellulose, cellulose or pectin. Dietary zinc averaged 
11 grams per day. Dry milk solids provided the only source 
of animal protein. Results indicat.ed that hemicellulose 
significantly increased fecal zinc excretion compared with 
the other fiber sources and with the basal diet. There were 
no significant differences in the other two fiber sources 
and the basal diet. Serum zinc did not change over the 
course of the study. However, the study was short and may 
not have allowed changes to be detected. While this report 
suggested that fiber might affect zinc absorption, the diet 
was very limited and contained no animal flesh sources of 
zinc. 
Effects of Felic Acid 
Both zinc and folic acid are essential nutrients for 
cell division and replication. There appeared to be a 
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relationship between these nutrients which affected the 
absorption of zinc in a study conducted by Milne et al. 
(55). They found that supplemental folic acid decreased 
zinc retention. Both urinary and fecal zinc excretion were 
increased during the control and zinc depletion stages of 
the research when 400 ug of pteroylglutamic acid was given 
every other day. 
Examination of plasma zinc levels during the experiment 
showed that plasma was sensitive to levels of zinc in the 
diet. With low dietary zinc and folic acid supplementation 
plasma zinc levels fell to a greater extent than with low 
dietary zinc and no supplementation. In addition, those 
subjects not receiving folic acid supplements had a more 
rapid rise in plasma zinc during repletion than those who 
received supplements. They stated that the observed 
decrease in both plasma and urinary zinc could result from 
folic acid inhibiting both the absorption and retention of 
zinc. Folate forms complexes with heavy metals; in this 
study the monopteroylglutamate presumably formed insoluble 
salts with zinc. 
To investigate the mechanism of the inhibition of zinc 
absorption by folate, Ghislan et al. (56) designed in vivo 
and in vitro experiments using male rats; charcoal binding 
studies were also conducted to determine if the inhibition 
were due to the formation of zinc-folate complexes. Results 
from both the in vivo and in vitro studies were that zinc 
and folic acid inhibit the absorption of each other. The 
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effect of f olate was in the gut because parenteral 
administration of folate had no effect on zinc absorption. 
Using cannulated adult rats, perfusions which contained only 
200 ug folic acid significantly reduced zinc absorption. 
The charcoal binding study results revealed that the 
inhibiting action of folic acid on zinc and vice versa was 
not due to a folic acid:zinc bound molecule. Altering the 
pH of the solutions resulted in Zn:folate binding at pH 2.0 
but the bond reversed when the pH was raised to 6.0. If 
similar binding took place in the living organism, the bond 
should be broken at normal intestinal pH. Thus, the effect 
of folic acid on zinc absorption was suggested to be at the 
membrane level. The results of these two studies caused 
questions to be raised on the effects of the use of f olic 
acid supplements by free-living persons consuming marginal 
zinc diets. 
Effects of Iron 
Solomons and Jacob (2) studied the effects on zinc 
absorption of adding heme and nonheme iron using a rise in 
plasma zinc as the measure of zinc absorption. Thirty-one 
adults participated in one or more of 46 absorption tests. 
Fasting blood samples were drawn before each testing period. 
After ingestion of a mixed test dose of 25 mg inorganic zinc 
(as 110 mg znso4 °7H2o) and nonheme iron in doses of 25, 50 
or 75 mg (as FeS04°7H20), blood was drawn hourly. The 
inclusion of nonheme iron significantly decreased the plasma 
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zinc compared to plasma zinc when only zinc was given. When 
measuring the rise in plasma zinc after the test dose as the 
indicator of the effect of nonheme iron, there was a 
decrease in the rise of plasma zinc. That is, nonheme iron 
resulted in decreased absorption of zinc. These differences 
were significant over the hours of the study except for the 
1:1 ratio of iron and zinc. Subsequent trials with nonheme 
iron demonstrated that nonheme iron did not affect zinc 
absorption when the zinc was in the "organic" form from raw 
oysters. Slightly different procedures were required when 
heme iron was studied due to the low solubility of heme 
iron. The heme was consumed directly into the mouth as a 
powder providing 75 mg elemental iron. The powder was 
immediately followed by the solution containing the zinc. 
Heme iron did not affect the absorption of zinc even at the 
3:1 ratio in which it was given. The methods used in this 
study showed changes in absorption rate only at quite high 
doses. While the doses were high, the iron:zinc ratios were 
kept constant at 1:1, 2:1, or 3:1. They suggested that when 
studying zinc status one should be cognizant of supplemental 
nonheme iron which may affect zinc status. 
In a further study Solomons et al. (3) studied the 
differences in absorption of ferric and ferrous iron and the 
effect which ascorbic acid had on the absorption of 
inorganic zinc. Ferrous iron reduced the absorption of zinc 
significantly at hours 1, 2, and 3 of the test while ferric 
iron did so only at hour 3 in the 2:1 mixture of iron:zinc; 
44 
f 
When ascorbic acid was added to the ferrous iron, no further 
decrease in the absorption of plasma zinc was seen. The 
researchers cautioned, however, that because the test dose 
was administered in an acidic soft drink the maximum effect 
of ferrous iron may have already occurred. When the 
ascorbic acid (1 g) was added to the ferric iron dose, the 
decrease in zinc absorption was significant at one hour. 
For this test plasma iron levels were available from studies 
in which the test was conducted both with and without the 
addition of ascorbic acid; in addition to decreasing zinc 
absorption, the ascorbic acid significantly increased the 
ferric iron absorption~ Iron status as determined by plasma 
iron also affected zinc absorption in the 2:1 iron:zinc test 
dose. Those with lower plasma iron levels and, hence, in 
greater need of iron showed greater inhibition of zinc 
absorption than those with higher plasma iron levels. These 
researchers also determined that consuming iron on 
consecutive days did not decrease the plasma zinc response 
to test doses more than the depression that occurred with 
the iron-zinc dose. The researchers stated that these 
pharmacological doses (25, 50 and 75 mg of iron per test) 
might not reflect the true picture that occurred with 
dietary intakes, but these doses were commonly available in 
nutrient supplements. 
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Effect of Protein 
Greger and Snedeker (57) investigated the effect of 
dietary protein and phosphorus on the utilization of zinc in 
eight young adult male subjects. The balance study 
consisted of a three day adjustment period followed by four 
12 day balance trials. Diets supplied either 8.1 g or 24.1 
g of. nitrogen and either 1010 mg or 2525 mg phosphorus 
daily. The subjects consumed test diets in which the 
protein level was modified by the use of either a "high" or 
"low" protein bread. The phosphorus was consumed with meals 
as potassium monobasic phosphate in solution. Zinc was held 
constant throughout the test periods. The basic diet was 
supplemented with fats and sugars to maintain caloric 
balance in each subject. When subjects were fed high 
protein moderate phosphorus diets, less zinc was lost in 
feces than when fed the other three test diets, but urinary 
zinc increased when high protein diets were fed. Serum zinc 
levels were higher when fed the high protein diets with no 
effect from phosphorus level or interaction of phosphorus 
and protein. Serum zinc was significantly correlated with 
urinary zinc but not with fecal zinc. Thus, the authors 
concluded that both level of dietary protein and phosphorus 
affect zinc absorption. 
Colin et al. (58) used college age women to study the 
effect of two levels of protein and of zinc on zinc 
absorption and retention. Twenty-four subjects were randomly 
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assigned to one of four dietary treatments. Results showed 
that urinary excretion of zinc was significantly greater on 
the high protein diet regardless of zinc intake. Although 
the retention of zinc did not differ significantly between 
the four treatments, only in the high protein high zinc diet 
was the net retention of zinc negative. Thus, at the levels 
of protein and zinc supplied in these test diets, increasing 
the protein did not affect zinc retention. 
Another balance study conducted at the Grand Forks 
Human Nutrition Research Center studied moderate protein 
intakes and the effects of these on zinc balance (59). The 
protein intakes of both diets were within the amounts 
commonly consumed by men and could not be considered high; 
they did exceed the Recommended Dietary Allowances, however. 
The diets were analyzed at 65 and 94 g protein. Again 
greater urinary excretion of zinc was found with the higher 
protein intake; while many minerals were held constant 
between the two diets, the high protein diet contained more 
phosphorus than the low protein diet. 
The zinc content of the two diets was held constant. 
Yet, urinary zinc increased when dietary protein increased. 
Thus, protein level is important in assessing zinc status. 
Regulation of Zinc Balance 
Evans et al. (60) postulated that the absorption of 
zinc may be regulated at both the apical and basolateral 
plasma membrane in rat intestine. If this applies to humans 
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as well, cellular structure in addition to intestinal 
contents might play a role in the absorption rate of zinc. 
In a study of healthy young adult males, Istfan et al. 
(61) reported that the zinc absorption rate was dependent on 
the zinc load. They found, using a liquid purified diet, 
that absorption of the 70zn tracer (either 1.19 or 4.52 mg 
dose) was approximately 81% when the zinc dose of 15 mg/day 
was divided equally into three meals. The rate of 
absorption decreased to 61% when the total zinc dose was 
24.52 mg/day. Istfan et al. suggested that the zinc 
nutritional status of the subject affected the rate of 
absorption. They also found a statistically significant 
increase in the absorption of zinc after only six days of 
maintenance on a diet which was low (1.5 mg/day) in zinc. 
When the dietary zinc dropped from adequate (15 mg/day) to 
low (1.5 mg/day), there was an immediate reduction in 
urinary and fecal zinc loss. If these results were found in 
mixed diets as well as in purified diets, zinc absorption 
and excretion rates would appear to be sensitive to dietary 
load. 
Possible roles for influence of carbonic anhydrase and 
albumin on the absorption of zinc during pregnancy and 
lactation were hypothesized by Moser and Reynolds (62). 
They found low intakes of dietary zinc both in ante and 
postpartum women whether or not they lactated. While the 
plasma zinc levels declined significantly during pregnancy, 
at delivery the cord plasma zinc was high. They inferred 
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the maternal decline in plasma zinc was a physiological 
response to the increase in blood volume, decrease in 
albumin, and increase in circulating estrogens of pregnancy. 
Erythrocyte zinc levels fell significantly one month 
postpartum to three months postpartum and again at six 
months postpartum. The researchers hypothesized that 
declining erythrocyte zinc was due to a decrease in carbonic 
anhydrase no longer needed at high levels due to decreasing 
the carbon dioxide load with delivery. This study suggested 
that an internal homeostatic mechanism for regulation of 
zinc absorption partly based on need may exist because no 
changes were found in plasma zinc during lactation and 
because erythrocyte zinc decreased during the six months 
postpartum with and without lactation. Further 
investigations are needed on the mechanisms regulating zinc 
absorption, metabolism and homeostasis. 
Baer and King (63) reported that the kidney may be a 
regulatory site for zinc homeostasis. This role was 
suggested based on experimental work with young adult men 
who showed a rapid increase in urinary zinc excretion at 
repletion following a low zinc diet. Thus, they believed 
that when intake of zinc was high, renal mechanisms 
functioned to excrete excess zinc and preserve tissue 
homeostasis. 
Evidence exists for association of several proteins 
with zinc in blood. Parisi and Vallee (64) found human 
plasma zinc associated with two protein fractions--albumin 
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and a zinc macroglobulin--by separation of serum or plasma 
chromatographically and with gel filtration. Zinc peaks 
paralleled those for alpha macroglobulin and albumin. 
Hahn and Evans (65) found in rats that following oral 
administration of 65 zn the radioactive isotope was found in 
four peaks with 40% in a low molecular weight ligand. Evans 
(66) has since reported evidence for several proteins 
associated with zinc in plasma. He suggested that albumin 
may be the transport protein to body cells and that . 
transferrin in the portal blood transported zinc from the 
basolateral plasma membrane to the liver. Evans (66) 
reported that isolated.rat intestinal cells when treated 
with a radioactive zinc dose did bind zinc to albumin and 
that albumin added to a solution of zinc bound cells draws 
the zinc to the albumin from the cells. Thus, they believed 
that albumin may have promoted the release of zinc from 
intestinal cells. It appeared that the association of zinc 
with different proteins may depend on the stage of 
absorption or transport to cells in which the zinc is found. 
Measures of Zinc Status 
Many studies have been conducted in attempts to 
determine appropriate measures for determining zinc status. 
None of these measures have provided conclusive evidence for 




Plasma has been recognized as an easily obtained tissue 
for evaluating components of body fluids. The validity of 
plasma as a measure of nutritional status depends on the 
existence (or lack of existence) of equilibrium between 
plasma and other body tissues. Plasma may be the means of 
transport from the gastrointestinal tract to functioning 
tissues rather than being in equilibrium with other body 
tissues. Nevertheless, zinc in plasma has been frequently 
evaluated as one measure of zinc nutritional status. 
Because of differences in reported zinc values from 
plasma and serum, researchers have expressed concern 
regarding the use of serum for zinc analyses. Serum may be 
contaminated with zinc from prolonged exposure to 
erythrocytes during coagulation or from rupture of platelets 
(67). Smith et al. (67) reported differences ranging from 8 
to 21% between serum and plasma zinc in a series of samples 
from ten subjects when 30% sodium citrate was used as an 
anticoagulant. Makino (68) stated a shift of water from 
erythrocytes to serum occurred accounting for lower zinc 
values in plasma than in serum. Zinc may be carried to 
serum in the water shift. 
The choice of anticoagulant may also affect 
comparability of results. Smith et al. (67) reported work 
of others which revealed that oxalated or citrated plasma 
had significantly (p<.1) lower zinc concentrations than did 
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plasma or serum in which heparin was the anticoagulant. The 
lower values in citrated and oxalated plasma were due to 
chelation of the ion. Thus, comparison of results between 
studies may be difficult. Heparin is frequently 
contaminated with zinc; Whitehouse et al. (69) used an ion 
exchange column (Chelex 100) to remove zinc from heparin and 
reported that three drops of 10,000 USP units zinc-free 
heparin was sufficient to prevent coagulation of three to 
seven milliliters of whole blood. 
Other sources of contamination also exist. Air, 
reagents, skin and saliva from technicians as well as blood 
collection apparatus must either be controlled and/or tested 
for contamination before use. Laminar flow clean air hoods 
with a rating of 100 are desirable in all sample 
preparations. Ultrapure acids and tested deionized water 
also must be used. Plastic labware must be tested because 
plastics suitable for one trace metal analysis may be 
contaminated for another (67). Sample storage was another 
possible source of error. Samples stored frozen may 
dehydrate especially when frost free freezers are used. 
Storage with ice cubes in sealed bags may prevent 
dehydration and thus concentration of the analyte (67). 
Smith et al. (67) stated that an analytical method 
must not only be "preferred, excellent and needed" but that 
it must also be "precise, relatively simple, inexpensive, 
and rapid." Most commonly zinc in plasma or serum has been 
measured using diluted samples with flame atomic absorption 
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spectrophotometry (AAS). The dilution level and the 
viscosity of the resulting solution must also be taken into 
consideration. 
In 1979 Smith and Butrimovitz (70) reported on a flame 
AAS method which used dilutions of one part plasma to four 
parts deionized water and standards of 50mL/L glycerol and 
water. The use of glycerol and water standards simulated 
the viscosity of plasma and thus controlled for differences 
in aspiration rate which would otherwise have interfered 
with the validity of the results. 
Rodriguez et al. (71) modified the procedure of Smith 
and Butrimovitz (70) by decreasing the concentration of 
glycerol to 30 mL/L in the standards. They reported that 
this glycerol concentration closely matched the aspiration 
rate found with a 1:4 plasma deionized water solution in a 
Perkin Elmer 5000 AAS. 
Solomons (72) has synthesized the work of many 
researchers to report factors which may affect plasma zinc 
levels. Zinc is known to be bound to albumin; if 
hypoalbuminemia existed in the subject then plasma zinc 
would be low. Hormones, both endogenous and exogenous, 
affect circulating levels as well. 
Plasma zinc levels vary in healthy subjects with time 
of day, fasting state, gender, medication usage, and age. 
Pilch and Senti (73) reported the serum zinc data from the 
second Health and Nutrition Examination Survey (NHANES-II) 
which showed that fasting and time of day of sample 
collection had great effects on the resulting values. 
53 
In the NHANES-II study males had significantly higher 
values than females for ages 9-74, but, in childhood, males 
had values lower than females of similar ages. Serum zinc 
rose during adolescence and peaked during young adulthood. 
Caution must be exercised in using these values as 
references, however, because in children the samples were 
drawn non-fasting. Age categories also present some 
difficulties because the ages preceding the expected growth 
spurt through maturation are grouped together. Mean serum 
zinc for white boys age 3-8 was 80.5±13.71 (mean+so} and for 
8-19 years 86.0+15.27 ug/dL. The data were adjusted for age 
and morning or afternoon collection of all samples, and for 
fasting using the fasting data for the males 20-74 years of 
age {73). Wagner et al. {48} reported serum zinc levels 
ranging from 101±12 to 119±18 ug/dL (mean ± SD} for males 11 
to 19 years of age according to stage of maturation. Buzina 
et al. {46} reported plasma zinc in chi"ldren with impaired 
growth ranging from 50 to >90 ug/dL with the mean of 74.7 
ug/dL. However, this group used tricholoracetic acid to 
precipitate the protein in the plasma; TCA has been shown to 
cause a decrease in plasma zinc levels because some zinc is 
also precipitated (70). Hambidge et al. (45} reported a 
mean ± SEM value for plasma zinc in boys age 33 to 90 months 
of 81.9±2.2 ug/dL. In a group of healthy preschool children 
who served as a control group, Hambidge found mean plasma 
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zinc of 84.2±2.9 ug/dL. Many researchers have reported 
values of <70 ug/dL to be associated with deficiency; 
however, due to changes in technology, age, maturation and 
gender of the subjects, setting a value for deficiency 
remains difficult. 
Plasma zinc was found to measure depletion only after 
variable periods of zinc deprivation. Apparently the length 
of time before plasma zinc levels fell was dependent on 
previous nutritional status of the subjects (63). Plasma 
zinc decreased only after urinary zinc fell to below 150 
ug/day. The level of plasma zinc continued to fall while 
the urinary zinc did not. 
Wada et al. (74) conducted a 75 day metabolic study in 
which a conditioning diet containing 15.5 mg Zn/d was fed 
for 12 days to six young adult men. A low zinc diet (5.5 
mg/d) was fed for 54 days, and then the conditioning diet 
was refed for the remainder of the study. Using stable 
isotopes they found that the mean decrease in serum zinc was 
insignificant when the diet changed from adequate to low. 
Even after seven weeks on the low zinc diet the lowest serum 
zinc concentration was 100 ug/dL. This concentration was 
not low enough to be considered abnormal by current 
definitions. 
Rabbani et al. (75) developed a model for the 
production of experimental zinc deficiency in humans. Their 
seven day cycle diet was fed for one year to volunteers in 
phases for stabilization, depletion (mean of 4.8 mg Zn/d for 
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28 weeks), and followed by a 20 week repletion phase (30 mg 
Zn/d). Plasma zinc decreased by 25% when the depletion diet 
had been fed for eight weeks. The differences between 
plasma zinc during baseline, depletion and repletion were 
not statistically significant, however. Lymphocytes were 
found to be more sensitive to both depletion and repletion 
than was plasma. The differences in lymphocytes between the 
three phases were significant at p<0.02. In this experiment 
not only was the depletion diet low in zinc, but also the 
phytate:zinc molar ration was high probably decreasing the 
absorption of zinc. 
While plasma zinc levels have been shown to vary with 
dietary treatment, Abdulla (76) stated that plasma zinc may 
not be a good measure of zinc status because about 98% of 
the total body zinc is intracellular; low plasma zinc could 
simply represent a shift from the transport media to another 
body compartment. While variation in plasma zinc levels can 
be demonstrated, Abdulla also stated that clinical signs of 
zinc deficiency are not usually seen until plasma zinc falls 
below 0.6mg/L. Because many factors can affect plasma zinc 
levels, this measure can be considered only a part of the 
assessment of zinc status. 
Erythrocyte Zinc 
Erythrocyte zinc is thought to reflect longer term 
status due to the slower turnover of zinc in red blood cells 
than in some other zinc responsive tissues. Depressed 
56 
erythrocyte zinc was found in studies of children with 
protein energy malnutrition (72). However, analysis of 
erythrocyte zinc and the significance of this measure were 
limited by research problems in analysis and interpretation. 
Some researchers reported that erythrocyte zinc remained 
high when plasma levels were low (72). In a study of 
preadolescent females, Kenney et al. (77) found that 
erythrocyte zinc increased with age and maturation stage 
although zinc intake decreased with increasing age. Thus, 
erythrocyte zinc, while not often measured in females of 
this age, may not be a good indicator of zinc status. 
Baer and King (63) investigated the response of tissues 
to zinc deficient diets in order to measure variation in 
tissue responses. Subjects were depleted until plasma zinc 
fell to <70ug/100 g. Length of depletion varied from four 
to nine weeks. They found that erythrocyte zinc did not 
fall during the five week depletion period in young men 
although plasma, urinary, and fecal zinc levels declined 
significantly. Their subjects' erythrocyte zinc levels were 
considered to be in the low normal range at the beginning of 
the study; therefore, further decreases in red cell zinc may 
not have occurred in the short period if they were marginal 
at the outset. It is questionable whether red cell zinc can 
be a useful measure of changes in zinc status. More 
information is needed about the mechanisms regulating the 
deposition of zinc in various body tissues. 
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Leukocyte Zinc 
Leukocytes contain about 25 times more zinc than a 
similar number of red cells, and total leukocyte zinc 
amounts to about 3% of all blood zinc (76). Meadows et al. 
(78) reported that the zinc content of peripheral blood 
leukocytes and. of operative and percutaneous muscle biopsy 
samples were strongly correlated in healthy individuals. In 
addition, this group reported that concentration of the 
nucleated tissue zinc could not be predicted from the zinc 
levels in plasma, urine or red blood cells. Abdulla (76) 
suggested that leukocyte zinc might be a good measure of 
zinc status but that careful separation and quantification 
of cells were required. 
Cholesterol Levels in Adolescents 
Serum cholesterol levels in adults have long been 
associated as a risk factor in atherosclerotic disease. 
Recently, concern has been expressed about the effect of 
childhood lipid levels on the development of heart disease 
later in life. While the current recommendations are that 
all adults should know their cholesterol levels, routine 
screening of children and adolescents has not yet been 
undertaken. 
Based on evidence that fatty streaks and raised 
atherosclerotic lesions have been found in young adults, 
Chase et al. (79) undertook an investigation of the 
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cholesterol levels and risk of.coronary artery disease in 
offspring of persons known to have had heart attacks early 
in life. Medical charts were screened for individuals in 
the Denver area known to have had a heart attack prior to 
age fifty. Both parents and all children were invited to 
participate resulting in a sample (58 heart attack victims, 
55 spouses, and 179 offspring) of approximately fifty 
percent of the.eligible subjects. All families were asked 
if they knew or had measurements of serum lipids prior to 
this study. Because only 4 of the total 71 families were 
aware of lipid levels prior to this study, knowledge of 
lipid levels was not thought to be a biasing factor for 
participation. Fasting blood samples were drawn from all 
subjects and from a control group of youth ages 12-20 from 
families with no history of heart disease. Mean cholesterol 
levels in the control group were within normal ranges for 
age. The study results revealed that 39% of the offspring 
of early heart attack victims had elevated lipid levels and 
that the pattern of abnormal lipids in the off spring was 
most commonly the same as the parent who had the heart 
attack. Fredrickson classifications of Type !Ia and IV 
(elevated cholesterol and low density lipoprotein or 
elevated triglycerides respectively) were most common in 
both the offspring and the parent. 
On the basis of their results, Chase et al. (79) 
recommended that all children of early heart attack 
individuals be screened for cholesterol level. If elevated, 
further definitive tests should be conducted. Screening 
only these children had the benefit of cost effectiveness 
because the normal controls has mean cholesterol levels 
within normal limits for their ages. 
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A study conducted in Beaver county, Pennsylvania (80), 
followed individuals nine years after original screening at 
age 12 to determine if early childhood screening could 
predict adult cholesterol values. Fifty-six percent of 
those eligible for the follow-up study actually 
participated. Because laboratory methods for analyzing 
cholesterol values had changed over the time period 
considered, results were compared by quintile rankings from 
initial testing to quintile rankings at retesting nine years 
later. Sex-specific distributions were used at both testing 
periods. Only data from the original screening for which 
follow-up data were also available was used in these 
analyses. Fifty percent of the men and 46.8% of the women 
in the top quintile during initial screening were found in 
the top quintile at follow-up; 66.7% of the men from the 
original top quintile were in the top two quintiles at 
follow-up. Those individuals who were incorrectly 
identified as high risk in youth due to placement in the top 
quintile were found to have healthier lifestyles than those 
who were incorrectly identified as low risk at initial 
screening. These researchers recommended that· screening in 
childhood should be conducted for all adolescents because 
waiting for a familial coronary event delays screening and 
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treatment. In addition, a positive family history was not 
more common in those correctly identified subjects than in 
those who were incorrectly classified as low risk during the 
initial testing. Orchard et al. (80) further recommended 
that the screening should include second screenings for 
total cholesterol and high density lipoproteins for those in 
the top quintile in the initial testing • 
. A study conducted by Vartiainen et al. (81) on 15 year 
old adolescents in Finland was designed to determine if 
children at risk for cardiovascular disease can be 
identified from the parent's history of disease. From a 
population of 4283 children, a sample of 1280 was selected; 
580 males (90.6% of the eligible males) and 610 females 
(95.3% of the eligible females) participated. 
Anthropometric measurements, sexual maturation according to 
Tanner standards, blood pressure and serum levels of total 
and HDL cholesterol were measured. The mean total 
cholesterol for males was 4.47 mmol/L (173 mg/dL) with 21% 
of the males having total cholesterol over 5 mmol/L 
(193 mg/dL). The data were also examined by sexual maturity 
stage. Decreases of 14% in HDL-cholesterol were associated 
with increasing maturation from stage 1 to stage 5. No 
association was found between total cholesterol and sexual 
maturation in either sex. No significant differences were 
found between mean values of the assessed risk factors in 
subjects from families with and without a history of 
cardiovascular disease. In addition, the proportion of 
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children with either high total cholesterol or low HDL-
cholesterol was the same in the group with a positive family 
history of heart disease as in those without such a family 
history. The researchers concluded that in this population 
children at risk for cardiovascular disease could not be 
identified solely by parents' history of the disease. 
In 1980 Christensen et al. (82) reported the results 
from the Prevalence Study of the Lipid Research Clinics 
Program for individuals under 20 years from the seven North 
American sites of data collection. This report provides 
data on a large number of children and adolescents {13,665) 
from industrial populations. While not a national 
probability sample, the values may be used as references 
because a variety of socioeconomic groups were included. 
Racial groups included were white and black. Trends in 
cholesterol values were detected when data were separated by 
age, sex, and race. White males showed no consistent 
pattern of differences up to age 11, but from age 11 until 
age 17 there was a consistent drop in the mean values {167 
to 156 mg/dL). Values for the 5% and 95% for age 12 were 
127 and 216 respectively. Standard deviations were similar 
at each age. For white males a similar inconsistent pattern 
of triglyceride values was found up to age 11, but, unlike 
cholesterol values, the triglyceride levels continued to 
rise to age 19. No data were presented for high density 
lipoprotein {HDL) values. 
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The decline in total cholesterol in females began about 
two years earlier than in the males. This fact as well as 
the ages at which these values decreased suggested that 
there might be an interaction between cholesterol levels and 
factors associated with puberty. 
During the 1973-74 school year, lipid data on 3,524 
children between the ages of 5 and 14 years were collected 
from the racially mixed community of Bogalusa, Louisiana 
(83). This sample represented 93% of all eligible children 
in that community. Results were presented by age, sex, and 
race as well as overall values. White males were found to 
have a similar lipid profile as reported in the Lipid 
Research Clinics data. Values remained rather consistent 
until age 11 at which time decreases in total cholesterol 
were seen as well as increases in serum triglycerides. 
Black children were found to have higher total serum 
cholesterol than white children. The authors cautioned that 
due to analytical error even in carefully controlled laos, 
which in this study resulted in a variation of 18 mg/dL, 
care should be observed in constructing a lipid profile from 
a single observation. 
A further report on the lipid values in the Bogalusa 
study presented data on lipoprotein levels in this group of 
children (84). High density lipoprotein (HDL) cholesterol 
concentrations were not found to correlate with age in any 
of the four race-sex groupings. Mean values for each age 
and the fifth and the ninty-f ifth percentile were given. In 
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white males (n=134) at age 12,.the mean HDL cholesterol was 
67 while the fifth and ninty-f ifth percentiles were 31 and 
101 respectively. A highly significant relationship was 
found between very low density lipoproteins and total 
cholesterol (r=.745, p<.0001) and triglyceride levels 
(r=.798, p<.0001) among white males. Highly significant 
correlations were also found for the relationship between 
total cholesterol and high density lipoproteins in both 
races; in addition, when differences between the racial 
groups were compared, blacks had significantly higher HDL 
levels than whites. 
Lauer et al. (85) investigated youth between the ages 
of 8 and 18 in Muscatine, Iowa, who were originally examined 
for lipid levels and were reexamined 12 years later as young 
adults. Reexamination studies included anthropometric 
measurements, family history, lifestyle practices as well as 
health histories. The purpose was to discover relationships 
between childhood and adult cholesterol levels. About 67% 
of those eligible actually participated· resulting in a 
sample of 2,446 white subjects. Data similar to that found 
in other studies were reported. In males mean cholesterol 
values increased from age 5 to approximately age 10, 
followed by falling levels until about age 15 at which time 
levels of total cholesterol began rising and continued to 
rise throughout the ages studied. Triceps skinfolds in 
males rose from age 7 until approximately age 12 when 
falling skinfold thicknesses were recorded. The decrease in 
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skinf old thickness continued until approximately age 16 at 
which time the thickness of the fat layer began to increase. 
This increase with age in fat layer thickness continued 
throughout the study. Correlations of childhood cholesterol 
in males with those levels in adulthood ranged from o.51 to 
0.72 and were significant. There were no significant 
correlations of childhood total cholesterol with adult high 
density lipoprotein cholesterol, but there were significant 
correlations between childhood total cholesterol and adult 
low density lipoprotein cholesterol levels although the 
correlations were somewhat lower (r=0.47 to 0.60). When 
factors related to obesity and other health habits were 
examined for prediction of adult cholesterol values, 
childhood cholesterol values were the best predictors; 
however, changes in the W/S2 added significantly to the 
prediction equation. Of the children who had cholesterol 
levels above the 90th percentile in the original testing, 
43% were above the 90th percentile at the adult measurement 
and 62% of these children were above the 75th percentile in 
adulthood. Based on the results of this study the 
researchers stated that lifestyle habits should be monitored 
as well as blood lipids because many of the habits acquired 
during adolescence persist into adulthood. The predictive 
value of childhood cholesterol levels was not above 50%, 
therefore, one should be cautious of single measurements for 
predicting adult levels or risk of coronary disease. 
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Fripp et al. (86) reported a study designed to measure 
the association between atherosclerotic risk factors and 
physical fitness and obesity. The sample was selected from 
289 tenth grade male adolescents who scored in either the 
low-moderate or moderate fitness level as determined by the 
Cooper walk-run test. One hundred males met the criteria 
and 37 volunteered to participate. Body mass index (W/S2) 
was used as the measure of obesity. In order to evaluate 
the effect of aerobic fitness on risk of atherosclerosis, 
subjects were divided into three groups based on oxygen 
consumption levels during fitness testing. The differences 
in risk factors between the three fitness groups were 
significant for body mass index and triglyceride levels. No 
differences were found in maximum heart rate between the 
three fitness groups, suggesting that all three groups were 
stressed to a similar degree. Body mass index, blood 
pressure (both systolic and diastolic), and triglycerides 
were positively related in linear regression analysis. 
There was a negative relationship between body mass index 
and triglyceride levels. In this group of male adolescents 
who were in the low-moderate or moderate fitness category, 
body mass index was the best predictor of the 
interindividual variability in the risk factors considered. 
While this sample was small, the results were similar to 
those of the larger Muscatine study (85). 
In a repeat testing five years after the initial study 
of the subjects in the Bogalusa Heart study, researchers 
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examined the relationship between changes in obesity and in 
serum lipids (87). Subjects ranged in age from 10 to 17 at 
retesting. Results indicated that increases in triceps 
skinfolds were positively related to changes in levels of 
total cholesterol, triglycerides, and both low density 
cholesterol (LDL-C) and very low density cholesterol 
(VLDL-C). There was a weak negative relationship to 
decreased HDL cholesterol levels. With the exception of 
follow-up levels of HDL cholesterol, all the associations 
were stronger in males than in females and were stronger for 
whites than for blacks. When regression models were 
constructed to assess the ability to predict follow-up serum 
lipid and lipoprotein levels from change in triceps 
measurements and initial lipid concentrations, the 
predictability increased significantly in white and black 
males for total cholesterol, triglycerides, LDL-cholesterol 
and VLDL-cholesterol by adding triceps skinf old thickness 
changes to the model. 
Black et al. (88) studied the effect of zinc 
supplements on serum lipids in non-smoking non-obese male 
volunteers between the ages of 19 and 29 from a university 
community. Subjects were given either supplements 
containing 50 or 75 mg Zn as zinc gluconate per day or a 
placebo containing all the ingredients of the supplement 
except for the zinc. Results from the twelve week study 
showed that the subjects receiving the zinc supplements had 
decreases in HDL-cholesterol;-there was a significant time 
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by treatment effect for the group receiving the larger zinc 
supplement. At week 12 there was a significant decrease in 
HDL-cholesterol for the 50 mg Zn group. There were no 
significant differences for any of the groups in total 
cholesterol, serum LDL- or VLDL-cholesterol. The placebo 
group had a higher HDL-cholesterol level at week 12 than at 
baseline. These researchers did not find that zinc 
supplemented free-living subjects had increases in 
cholesterol levels as had been found in animal studies. 
Dietary records kept by subjects did not reveal significant 
differences in energy, fiber, calcium, or copper between 
groups although not all days were recorded. The group 
receiving the 75 mg Zn supplement consumed significantly 
less zinc, protein, total fat and saturated fatty acids than 
the other groups. Because the doses in the supplements were 
amounts commonly available, the researchers stated that long 
term use of these levels of zinc supplements could have a 
harmful effect on cardiovascular health. 
While many of these studies have shown a tendency for 
cardiovascular risk factors to be heritable and while many 
children and youth seem to be "at risk" in terms of serum 
lipid levels, the Committee on Nutrition for the American 
Academy of Pediatrics in 1986 (89) restated their earlier 
opinion on the inadvisability of altering or severely 
restricting the dietary patterns of children in their 
growing years. They were particularly cautious about 
recommendations restricting fat and cholesterol intakes 
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during the adolescent growth spurt. They supported 
screening children over two years of age who were at risk 
for heart disease due to family history for blood lipid 
levels; screening should consist of at least two 
measurements and further testing for HDL-cholesterol if the 
lipid levels were found to be above the 95th percentile for 
age and sex. 
Dietary Assessment Methodology 
The purpose of a study has a direct bearing on the 
method of dietary assessment. If the object is to determine 
nutrient intakes for groups of people then the methodology 
should be different from that used to determine 
relationships between disease and specific nutritional 
habits of an individual (90). The commonly accepted 
techniques for dietary assessment each vary in their 
strengths and limitations. The validity of any method is 
dependent on the intelligence, motivation, and cooperation 
of the subjects as well as on the techniques and skills of 
the interviewer. Rapport needs to be established between 
the subject and the interviewer if complete information is 
to be obtained (91) . 
Most zinc status measures do not respond immediately 
low dietary intakes. In fact, it appeared that over time 
the body adjusted somewhat to lowered intake or less 
available intakes by increasing the absorption rate (63). 
to 
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Therefore, dietary assessment measures used to help explain 
zinc status need to reflect long term or usual intake. 
Nutritional History 
The diet history developed by Burke (92) in 1947 
assessed the usual intake of an individual over a period of 
time. This method required a highly skilled interviewer and 
considerable time for data collection. The time period for 
which data were collected was determined by the purpose of 
the study, the frequency of collection, and the ability of 
the subject to remember usual intakes. 
In collecting the nutritional histories, the researcher 
needed to be aware of the subjects' ability to estimate 
portion sizes and to remember foods consumed. Generally, 
females under the age of 12 and males less than 13 to 14 
were unlikely to give reliable nutritional histories (91). 
Training of the subject in observation was essential 
for accurate results in longitudinal studies. Beal (91)" 
found in the Denver longitudinal studies of children that 
the first nutritional history from a subject should be used 
only as an information trial and then discarded due to the 
multiple inaccuracies. This initial nutritional history 
served as training of the subject for observation and detail 
needed in conducting the research. 
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Twenty-four Hour Intake Records 
Research on the validity of the 24-hour dietary intakes 
revealed that this method, when used as the only basis for 
data collection, may be acceptable in large group studies in 
which time, money, and personnel are limited; however, these 
records were inadequate for determining individual 
relationships between diet and effects of the diet in 
longitudinal research (91,93,94). One of the chief 
advantages of the method was the shorter time required for 
collection than that required for the nutritional history. 
In addition, a less-highly trained and skilled interviewer 
was needed than was required for the history (90). 
According to Beaton (93), one of the chief drawbacks to 
the method is the false negativity in correlations due to 
the lack of reflection of usual eating patterns. Because of· 
the large intraindividual variation in daily intakes, a 
single 24-hour recall also biased the slope of the 
regression analysis toward zero and, thus, did not identify 
relationships effectively. 
Food Records 
Food records vary in length of time for which 
information is recorded. They may be either weighed records 
or estimates of portion sizes. A seven-day record, thought 
to give a more accurate estimate of intake than a single day 
record, demands a high degree of cooperation on the part of 
the subjects (90). In addition, an interviewer needs to 
review the record with the subject to clarify information 
and to fill in missing information. 
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Hackett et al. (95) found the diary method satisfactory 
for a two year study with children who were age eleven at 
the beginning of the study. They found a high degree of 
compliance in three day records which were repeated five 
times during the study. Because they were interested in the 
relationship between dietary habits and macronutrient 
intakes, they felt the method was satisfactory. They did 
not evaluate vitamin or mineral intakes. 
In a study of 44 elderly persons Gersovitz et al. (96) 
found that the first two days of the seven day record 
significantly correlated with foods actually consumed, but 
that the accuracy of the record keeping deteriorated during 
the last three days. Thus, the method may again give good 
information on group intakes but was more limited for 
estimates of individual intakes. 
Balough et al. (97) compared the results of the average 
of several 24-hour recalls with a shortened version of a 
diet history. They found the correlations were high for 
calories, protein, carbohydrate and fat. The 24-hour 
recalls were obtained over eight months; thus, this level of 
precision required subject availability and cooperation. It 
also increased the length of the study and interviewer time. 
Due to the high intraindividual variability they found that 
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nine 24-hour recalls would be required to accurately reflect 
the usual intake of 90% of their population. 
CHAPTER III 
RESEARCH METHODS 
Methods of data collection and analysis are described 
in this chapter. Selection of subjects, anthropometric 
measurements, biochemical measures, and method of dietary 
intake assessment are included. 
Research Design 
The present study was designed as a correlational 
descriptive study. Controls established were age, gender 
and apparent good health. Because the purpose was to 
describe differences in adolescents related to maturation, 
it was necessary to limit the age range of subjects. 
Controlling for age and gender provided group sizes 
sufficient for analysis without necessitating a very large 
sample. Controlling for health reduces the potential for 
unexplainable intervening variables. This control for 
health can also be considered valuable in reducing the total 
sample size needed. 
Data were collected between February and June 1988. 
Subjects were scheduled for laboratory visits in the order 
in which interviews were conducted, as much as possible. 
Care was taken to prevent a child who was interviewed early 
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in the study from being scheduled for laboratory measures 
late in the study. Interviews were conducted in settings in 
which the adolescent was comfortable; most were conducted in 
the adolescent's home. 
Selection of Subjects 
The target population was adolescent males in 
different stages of maturation. The subjects were 
volunteers from the ages of 10.6 to 14.3 years who were 
invited by letter to participate. 
A preliminary announcement (Appendix B) of the project 
was sent to parents of eligible subjects. The announcement, 
on bright yellow paper, was sent to elicit interest before 
the longer more detailed letter was sent. The announcement 
was timed to arrive one week before the letter. 
The adolescents attended the Stillwater Middle School, 
Stillwater, OK. From a total male student population of 
333, letters of invitation were sent to 241 for whom 
addresses could be located using a cross-listed telephone 
directory. Of the 241 letters which were sent, nine were 
returned as unable to be located. Cards, enclosed in the 
letters, expressing interest in the study were returned or 
telephoned inquiries were received from parents of 66 
adolescents. Three parents also volunteered younger sons 
who met the age criteria but who were not enrolled in Middle 
School. Three volunteers were lost either by not being able 
to contact a parent for an appointment (2) or by family 
relocation before the study began. The final sample 
included 66 adolescent males. All subjects completed all 
parts of the study with the exception of one for whom a 
complete blood sample could not be obtained. 
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Prior to the selection of subjects, the study received 
approval from the Internal Review Board at Oklahoma State 
University for studies involving human subjects. Informed 
consent was obtained from at least one parent and from the 
subject (Appendix C). 
Rewards for participation were given. All subjects 
received a coupon for a fast food item1 , tokens for two 
games at a video game entertainment center, and two dollars. 
A drawing for six $25.00 gift certificates was held. All 
participants' names were entered into the drawing on the day 
of blood collection. Each child had a one in eleven chance 
of winning a gift certificate. 
Anthropometric Measures 
All anthropometric measurements were made on the day 
that blood samples were collected. Mid-arm circumference 
and three triceps skinfold measures using Lange calipers 
(Cambridge Scientific Industries, Cambridge, MD) were taken 
on the right arm by one trained nutritionist. Height was 
measured without shoes using a steel tape affixed to a 
1 Donated by McDonald's, Inc., Stillwater, OK 
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perpendicular surface with a right angle head board. 
Subjects were weighed in street clothes without shoes on a 
beam balance-calibrated before the study began. Arm muscle 
area and body mass index (W/S2) were calculated from these 
measurements. 
Height percentiles were determined using maturation 
based growth charts (12) obtained from Castlemead 
Publications (Hertsfordshire, England) and are included in 
Appendix D. Skinfolds were evaluated using the reference 
values from Frisancho (18). All anthropometric procedures 
are included in Appendix D. 
Blood Collection and Analyses 
Fasting blood samples were drawn by a registered 
medical technologist using plastic syringes with plastic 
pistons (Sarstedt, Numbrecht, W. Germany) and 21 gauge 
stainless steel butterfly needles (Deseret Medical, Inc., 
Sandy, Utah). Three drops of heparin (10,000 USP units/mL) 
which had been passed through a prepacked ion exchange 
column (Chelex 100, Bio-Rad Industries, Richmond, CA) to 
remove contaminating zinc were used as an anticoagulant in 
the tubes for collecting plasma. The whole blood was kept 
in an ice bath until analysis of hemoglobin and separation 
of plasma. 
Blood was separated in a Beckman TJ-6 refrigerated 
centrifuge at 1520 x g for 22 minutes at 4°c. Plasma was 
transferred to acid washed plastic tubes, capped and stored 
frozen until plasma zinc and DHEAS were analyzed. Plasma 
for cholesterol determinations was stored refrigerated 
overnight. 
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Hemoglobin was measured by the cyanmethemoglobin method 
using prepared reagents (Sigma procedure 525, Sigma Chemical 
Co., st. Louis, MO). Whole blood measurements were made 
within three hours of blood collection. 
·Total and high density lipoprotein cholesterol in 
plasma were measured by an enzymatic colormetric method 
using a kit (Sigma procedures 351 and 352-3). Absorbance 
was read at 500 nm on a Gilford Response Spectrophotometer 
(Oberlin, Ohio). Values were compared to those for 
adolescents from the Lipid Research Clinics trials (82). 
Maturation status was assessed using dehydroepiandros-
terone sulfate as a marker. This adrenal androgen has been 
shown to have little diurnal variation and to increase 
progressively with age and maturation status (31). A double 
antibody radioimmunoassay kit (Cambridge Medical 
Diagnostics, Billerica, MA) was used to determine the plasma 
level of the hormone. 
Plasma zinc was determined using an air-acetylene flame 
with a Perkin-Elmer 5100 PC atomic absorption 
spectrophotmeter (Norwalk, CT). Wavelength was set to 213.7 
nm with a slit of 0.7 nm. Acetylene flow rate was 1.9 L/min 
and air was 10.5 L/min. The integration time was 3 seconds. 
Calculations were based on mean peak area for two 
replicates. 
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A modification of the procedure of Rodriguez et al. 
(71) was used for plasma zinc analyses. Samples were 
prepared by dilution of 400 uL plasma with 1.6 mL 0.5% 
nitric acid (GFS Chemicals, Columbus, Ohio). Purified water 
tested to contain less than 0.005 ug/mL zinc was used in 
preparation of the nitric acid. The same bottle of water 
was used for all steps of the analysis. Standards of O and 
0.4 mg/L zinc were prepared in 30 g/L certified 
glycerol/0.5% nitric acid. Glycerol, used in the standards, 
alters the viscosity of the solution resulting in an 
aspiration rate very similar to the diluted plasma samples. 
Aspiration rates are important because the calculations are 
based on mean peak area within a specified time. Nitric 
acid in the standards and samples enhances the absorption 
signal to the photomultiplier tube. After each sample 
reading the tubing and nebulizer were rinsed with 0.5% 
detergent (ERA, Proctor and Gamble, Cincinnati, OH} solution 
to prevent clogging of the tubing, nebulizer or burner head. 
Water was then aspirated until a normal flame returned. 
Standards and a control sample of plasma were periodically 
reread. Corrections were made to readings based on slight 
baseline drift. Specific procedures for each biochemical 
determination are included in Appendix E. 
Dietary Intake Records 
Estimations of usual eating habits were determined 
using a specially constructed·food frequency questionnaire 
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(Appendix C). The questionnaire was developed using foods 
commonly eaten in Oklahoma with the additions of foods known 
to be especially rich sources of zinc. The questionnaire 
was pretested in volunteers (n=l37) at the Stillwater Junior 
High School in the Fall of 1986. Foods not commonly 
consumed by youth of this age were eliminated unless they 
were outstanding sources of zinc. This group was selected 
for pretesting the questionnaire because of the similarity 
of age without biasing the actual sample. 
Frequency of consumption and estimations of usual 
portion sizes were determined. To assist the subjects in 
estimatin9 portion sizes specially constructed food models 
were used which have been shown to be non-biasing (98). 
Food model sizes ranged from one teaspoon to 2 cups. Models 
for estimating meat and cheeses were made from various 
thicknesses of cardboard using the directions from osu 
Cooperative Extension Weigh-Off program. Glasses with marks 
for 4, 6, 8 and 12 ounces were used for beverages. When· 
brand name items were reported by subjects, portions sizes 
were based on published values. 
From the frequency and portion estimates amounts 
consumed per day were calculated using the figures of seven 
days per week and 30 days per month. For example, the 
portion size (quantity) was multiplied by the frequency of 
consumption and then divided by the appropriate time period. 
If a food were eaten three times per week, the quantity was 
multiplied by three and divided by seven. Subjects were 
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asked to recall foods consumed for approximately 4 months. 
The Food Processor II (ESHA Research, Salem, OR) was used 
for dietary analyses. The data base included fast food 
items commonly consumed. For foods not listed in this 
software product, values were calculated from product labels 
and added to the data base. 
Health Background 
A questionnaire for collecting health habits and family 
and subject background information was completed by 
interview at the time of the dietary intake collection 
(Appendix C). This questionnaire was developed to identify 
unmeasured variables which might explain unexpected or 
"abnormal" results. 
Statistical Analyses 
All data were analyzed by the Statistical Analysis 
System (SAS) version 5.18 (SAS Institute, Cary, NC) on a 
mainframe IBM model 3081 computer. 
Correlation coefficients were calculated in preliminary 
analyses to identify relationships between key variables 
identified or hypothesized from published research. Means 
and standard errors of means were calculated by age and 
DHEAS groups in growth and maturation characterization of 
the subjects. 
In analyzing plasma zinc, data were examined for 
differences using the GLM procedure by grouping data within 
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variable categories. Plasma zinc groups were divided into 
tertiles. Differences in least squares means of categorical 
groups were analyzed by the general linear models (GLM). 
Regression models were constructed by stepwise 
regression calculations entering variables which were 
related from previous analyses or which had been identified 
in published research as associated with t:pe dependent 
variables. Overall statistical significance was set at 
p=0.05 for all analyses in this study. 
CHAPTER IV 
DEHYDRODEPIANDROSTERONE SULFATE, CHOLESTEROL, HEMOGLOBIN AND 
ANTHROPOMETRIC MEASURES RELATED TO GROWTH 
IN ADOLESCENT MALES 
Introduction 
Adolescence is a time of rapid growth and sexual 
maturation and of self-consciousness. Physiological changes 
during this period necessitate adequate nutrient intake. In 
order to assess adequacy of nutrient intake a measure of 
maturation status is desirable. Plasma dehydroepiandro-
sterone sulfate (DHEAS) rose with increasing maturation 
evidenced by Tanner staging (1) and was related to changes 
in bone age (2,3), another measure of increasing maturation. 
Maturation may be a determinant of increasing hemoglobin 
levels found with increases in age in males during 
adolescence (4-7). During adolescence cholesterol levels in 
males decreased with age up to usual maturation age and then 
again rose (8,9). The purpose of this study was to 
determine relationships between measures of maturation and 






The sample consisted of 66 apparently healthy white 
male adolescent volunteers between the ages of 10.6 and 14.3 
years. Subjects were generally from an upper middle income 
background, primarily children of university faculty 
members. The study was approved by the Internal Review 
Board at Oklahoma State University for studies involving 
human subjects. After explaining all aspects of the study 
to the subjects and parents, informed consent was obtained 
from at least one parent and from each subject. All 
subjects, except for one from whom a complete blood sample 
could not be obtained, completed all aspects of the study. 
Anthropometric Measures 
Subjects were weighed and measured in light street 
clothing without shoes on the morning of blood collection. 
A calibrated beam balance scale and steel tape with right 
angle head board were used for these measures. The same 
person measured and weighed all subjects. Triplicate 
triceps skinfolds using Lange calipers (Cambridge Scientific 
Instruments, Cambridge, MD) and midarm circumference were 
measured on the right arm by the same individual. These 
measurements were compared with national norms from NHANES-I 
data (10). Height percentiles were determined using 




Fasting ve.nous blood was drawn using 21 gauge stainless 
steel butterfly needles (Deseret Medical, Inc., Sandy, Utah) 
and plastic syringes (Sarstedt, Numbrecht, w. Ger.) with 
heparin, which had been passed through a chelating resin 
column (Chelex 100, Bio-Rad Industries, Richmond, CA}, as an 
anticoagulant. Blood samples were kept on ice until 
processed. Plasma was separated by centrifugation at 1520 x 
g for 22 min at 4° c. Plasma was immediately transferred 
with polyethylene pipets to acid washed polyethylene storage 
tubes. Plasma for total and high density lipoprotein (HDL} 
cholesterol was refrigerated for no more than 24 h until 
analysis. Plasma for DHEAS determinations was stored 
frozen. 
Hemoglobin and Cholesterol Measures 
Hemoglobin was determined on whole blood within three 
hours of drawing by the cyanmethemoglobin method (Sigma 
Procedure 525, Sigma Chemical Co., St. Louis, MO). Results 
were compared to norms for age. Total and HDL cholesterol 
were determined enzymatically (Sigma Procedures 351 and 
352-3). Results were compared .to those in similar aged 
males in the Lipid Research Clinics trials (9). 
Maturation status 
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Dehydroepiandrosterone sulfate (DHEAS) was used to 
assess maturation status. A double antibody 
radioimmunoassay (Cambridge Medical Diagnostics, Billerica, 
MA) requiring 10 uL plasma was used to assay this adrenal 
hormone. DHEAS concentrations were compared to reference 
values established for a pediatric population (1) with 
categories set at <3 umol/L for Group I, 3-6 umol/L for 
Group II and >6 umol/L for Group III. 
Age 
Age was determined from birth to day of anthropometric 
measurements and blood collection and was expressed in 
years. If a subject were less than 12.00 years on the day 
of data collection, he was classified in "Age Group 11." 
Those more than 12.00 and less than 13.00 were classified as 
"Age Group 12", and those more than 13.00 were classified as 
"Age Group 13." Only one subject was actually less than 
11.00 and two more than 13.00 years. 
Nutrient Intake 
Nutrient intakes were determined using a pretested 
quantitative food frequency questionnaire. Portions were 
estimated using nonbiasing food models (12) in amounts 
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ranging from 1 tsp to 2 c. Subjects were asked to recall 
food consumed for approximately four months. Data were 
converted to amounts consumed per day and analyzed using the 
Food Processor II (ESHA Research, Salem, OR). Nutrient 
supplement data were obtained from label values and were 
included in total daily intakes. Values consumed were 
compared to appropriate standards for age in the Recommended 
Dietary Allowances (13). 
statistical Analyses 
Results are presented as means ± SEM by age, DHEAS, and 
iron supplementation groups. Two subjects whose triceps 
skinf olds exceeded 2 SD of the mean were eliminated from all 
calculations. Correlation coefficients were calculated for 
variables related to growth and maturation. When 
significant relationships were found, analysis of variance 
for predetermined groups was calculated using the General 
Linear Model (GLM) for unbalanced groups. Regression 
equations were constructed to determine the variables which 
best predicted maturation. The Statistical Analysis System 
(SAS) version 5.18 (SAS Institute, Inc., Cary, N.C.) was 
used for all calculations. 
Results 
Age 
Adolescence is a period of rapid growth and 
development. However, maturation is highly individualized 
by development and not by chronological age. Means of 
anthropometric data for the sample were within 5% of 
national norms (10) in all age groups. 
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Age categories revealed significant differences in 
height at each age category but significant weight 
differences were reflected only between the youngest and 
oldest groups (Table 1). Significant differences existed 
for midarm muscle area (MAMA) between Age Group 11 and Age 
Groups 12 and 13 and not between Age Groups 12 and 13. 
There were no significant differences in body mass index 
(W/s2 » nor were there significant differences in DHEAS, 
hemoglobin or total and HDL cholesterol concentrations among 
any of the age groups (Table 1). 
Maturation 
DHEAS groupings documented differences in subjects' 
development according to maturation. Age of the subjects in 
the three groups was not significantly different (Table 2). 
Significant differences between Group I and those in Groups 
II and III were seen in height, weight, muscle development 
and hemoglobin (Table 2). Differences in body mass index 
(W/S2) were found between Group I and Group II. In 
contrast, by age groups there was no pattern to body mass 
index (W/S2). Significant positive correlations (p<0.01) 
were found between DHEAS concentration and height (r=0.34), 
weight (r=0.35), and MAMA (r=0.33), as well as significant 




Cholesterol concentrations were similar to those 
reported by Christiansen (9). The tendency for cholesterol 
to decline during adolescence was seen in this sample by age 
groupings although the differences were not significant 
(Table 1). These trends, again not significant, were also 
seen between DHEAS groups I and II with groups II and III 
lower than those in group I. Significant negative 
correlations were found between cholesterol and height (r=-
0. 36, p<0.004) and measures of muscle development MAMA (r=-
0.35, p<0.005). Differences in HDL cholesterol values 
between maturation groups II and III were significant, but 
no significant differences were found between group I and 
groups II or III. No differences were seen in HDL levels 
with age changes. 
Hemoglobin 
The differences in mean hemoglobin concentration among 
the DHEAS groups were between Group I and Groups II and III 
(Table 2). The same pattern of significance among the DHEAS 
groups existed for hemoglobin as for other measures which 
were associated with greater maturation: height, weight, 
w;s2 , and MAMA. Mean hemoglobin levels were the same for 
all age groups. Hemoglobin levels were significantly 
correlated with DHEAS (r=0.28, p<0.03) but not with age. 
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When subjects were grouped by those receiving 
supplements containing iron and those not receiving 
supplemental iron, no differences were seen in age, DHEAS, 
hemoglobin, height,or weight (Table 3). While there were 
differences in estimated mean intakes of nutrients between 
these two groups, there were no differences in the nutrient 
ratios of iron:vitamin c, zinc:copper or iron:zinc. 
Hemoglobin was not significantly related to total intakes of 
any of these nutrients nor was it related to the ratios of 
nutrients in the diet. Nutrient intake as estimated in this 
study did not affect hemoglobin level. 
Prediction of Dependent Variables 
Height, weight, W/S2 , MAMA and hemoglobin were all 
related either to age or DHEAS or both. Regression 
coefficients were calculated with age and DHEAS as 
independent variables and these characteristics of 
maturation as dependent variables to determine the better 
predictor. DHEAS was a better predictor for W/S2 , MAMA, and 
hemoglobin and was similar to age in predicting weight. Age 
was a stronger predictor than DHEAS only for height. 
To illustrate the interplay of these variables in 
relation to a maturation characteristic a regression 
equation was generated for MAMA using DHEAS, weight, 
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hemoglobin, age, W/S2 , and height as variables. The R2 was 
0.55 and overall significance was p<0.0001. 
Nutrient Intake 
This sample was well nourished as evidenced by adequacy 
of mean nutrient intakes. As a group, nutrient intakes 
exceeded the RDA for protein, iron, zinc, calcium, folacin 
and vitamin c. · No differences were found in nutrient 
intakes either between age groups or between maturation 
groups except for protein. Overall, subjects in DHEAS group 
III reported consumption of significantly less protein than 
the subjects in DHEAS group II; however, the calculated 
intake for all groups was well above the Recommended Dietary 
Allowance (13) for adolescents. Mean copper intake was 
slightly below the lower limit of the estimated safe and 
adequate level for adolescents. While intakes of vitamins 
and minerals were higher in supplement users, most users 
consumed multivitamin or multivitamin-mineral preparations 
resulting in no change in mean ratios or nutrients. 
Discussion 
Adolescence is a period of rapid growth, maturation and 
self-consciousness. The age of onset of puberty is highly 
variable, generally occurring later in males than in 
females. Because nutrient needs and nutritional status may 
vary with maturational state, assessment of nutritional 
status in this age group should consider the pubertal 
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changes in the individual. Due to the self-consciousness in 
this age, maturation assessment without the embarrassment of 
physical examinations should increase willingness to 
participate in research. Reiter et al. (14) have reported 
continuous increases in DHEAS with increases in bone age up 
to bone age of 16 y. Katz et al. (2) also related DHEAS 
levels to bone age. Those with low levels of DHEAS had 
delayed bone age, and increasing levels of DHEAS were 
associated with increases in bone age. Lee and Migeon (3) 
found that elevations of DHEAS occurred after Tanner 
pubertal Stage I and occurred with the appearance of pubic 
and axillary hair. In a large pediatric population Babalola 
and Ellis (1) related plasma DHEAS to Tanner's stages of 
sexual maturation. Plasma DHEAS <3 umol/L was not found in 
those males in Stage V pubertal development. Those between 
3 and 6 umol/L were primarily in Tanner's stages II and III. 
Considerable overlap in DHEAS levels were found in Tanner' 
Stages IV and V. Katz et al. (2) also found significant 
relationships between DHEAS and increased body fat. In this 
study evidence for DHEAS as a marker for maturation was 
given support by increases in body mass index, arm muscle 
area as well as increased height and weight that occurred 
with increases in plasma DHEAS concentration. 
Dallman and Siimes (4) developed percentile curves for 
hemoglobin levels throughout infancy and childhood showing 
an increase in the slope of the curve at age 12 y; the 
increased slope was particularly noticeable for those above 
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the 90th centile. Others have also related increases in 
hemoglobin to increased age (5-7). Several groups (4-6) 
have expressed the need for determination of sexual 
maturation in interpretation of hemoglogin values because 
the onset of puberty contributes to the spread in values 
seen within age groups. Variability in iron status measures 
was commonly found in males between the ages of 11-14 when 
NHANES-II data were analyzed (5). The data did not show 
significant differences between hemoglobin by age groups but 
a noticeable change in hemoglobin values occurred as the 
subjects changed from the DHEAS group I to DHEAS group II 
(p<0.03). The fact that the hemoglobin level did not appear 
to be related to dietary factors or to the use of nutrient 
supplements in adolescent male populations has also been 
documented by others (6,15). 
Screening children for cholesterol levels as a means of 
predicting coronary artery disease risk in adulthood has 
been discussed for several years. Based on present 
knowledge the American Academy of Pediatrics does not 
recommend routine screening at this time nor do they 
recommend dietary changes for children and adolescents (16). 
Cholesterol values have been shown to decrease with 
increasing age during adolescence (9). Other studies have 
related childhood risk factors to adult coronary artery 
disease (17-19). In this study plasma cholesterol 
concentration was negatively correlated with age, DHEAS, and 
hemoglobin, but these relationships were not significant. 
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Nevertheless, cholesterol was negatively correlated with 
height (p<0.004), weight (p<0.01), and MAMA (p<0.005), 
measures which were positively associated with DHEAS levels 
(p<0.008). The decrease in cholesterol concentration was 
greater between DHEAS groups I and II than were the 
decreases between any of the age groups. Perhaps there were 
no significant differences in cholesterol levels either by 
age or by maturation groups in our sample because our 
subject selection was from a deliberately narrow age range 
in the attempt to identify maturation changes. 
It is well known that during puberty males increase 
rapidly in height and undergo great changes in body 
composition. The data support the relationship between 
DHEAS and maturation when evidence of maturation includes 
the characteristics of increased height, weight, muscle 
development (MAMA), W/s2 , and increased hemoglobin. These 
differences were seen between DHEAS group I (DHEAS <3 
umol/L) and group II (DHEAS 3-6 umol/L). While 
chronological age also separates some of the maturation 
characteristics of these subjects, fewer were significant by 
age groups than by DHEAS groups. Significant differences in 
variables were not found between the same age groups for all 
characteristics. Because nutritional needs of adolescents 
are associated with growth and development rate, 
determination of maturational status in survey work is 
important. We suggest the use of DHEAS as a relatively 
simple indicator of change in maturation status which 
eliminates the embarrassment of physical examinations in 








Weight, kg 4 
W/S2 




11. 5±0. 2 
148.0±2.1 



















161. 5±1. 6 c 




Cholesterol, mmol/L 3.97±0.2 3.74±0.11 3.72±0.09 
HDL, mmol/L 1.32±0.08 1.19±0. 04 1.27±0.03 
DHEAS, umol/L 4.1±1.0 4.00±0.4 4.9±0.3 
1 Row means with different superscripts are significantly 
different 





Indices of growth and maturation by DHEAS groups1 
Variable Group I Group II 
<3 umol/L 3-6 umol/L 
n=13 n=40 
Age, y 12.7±0.2 12.9±0.1 
Height, cm 2 152.8±2.1 a 159.0±1.5 b 








W/S2 3 16.6±0.3 a 19.4+0.4 b 18.5+1.la,b 
MAMA, cm2 3 28.4+1.2 a 35.6±1.1 b 36.0±2.6 b 
Hemoglobin, g/L2 131.9±3.1 a 142.1+2.3 b 145.5±4.1 b 
Cholesterol, mmol/L 3.94±0.14 3.70±0.10 3.76+0.08 
HDL, mmol/L2 1.23±0.05ab 1.22±0.03 a 1.36+0.06 
DHEAS, umol/L4 1.9±0.2 a 4.5±0.1 b 7.4±0.3 c 





































TABLE 3 (continued) 
Non-users Users 
n=47 
Nutrient intake characteristics 
Protein, g 110+6 124±10 
Iron, mg 3 18+1a 33±2b 
Zinc, mg 3 16±1a 27±3b 
Copper, mg 3 1.6±1.0 a 2.7±0.3 b 
Folate, ug 3 427+3la 674+53b 
Vitamin c, mg 4 164±18a 277+34b 
Iron:zinc, mg:mg 1.18: 1 1.36:1 
Iron:Vit. c, mg:mg 0.16:1 0.14:1 
Zinc: copper, mg:mg 10.1:1 10.6:1 
1 Row means with different superscripts are significantly 
different 
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CHAPTER V 
PLASMA ZINC IN RELATION TO GROWTH AND MATURATION IN A 
SAMPLE OF ADOLESCENT MALES 
Introduction 
Zinc is required for growth and sexual maturation. In 
the 1960's clear documentation of the importance of zinc in 
maturation was shown by investigators in the Middle East 
(1-4). Others have reported suspected zinc deficiency in 
children with growth retardation (5-10). IIn some studies 
zinc supplementation has resulted in significant changes in 
growth achievement (7,10). These studies have frequently 
reported greater incidence of suspected zinc deficiency in 
males than in females (5,7,11-13). 
·Because adolescence is the period of sexual maturation 
and rapid growth, the need for zinc would be expected to be 
high. Many biochemical measures have been suggested for 
assessing zinc status (14), yet plasma zinc is commonly 
reported as the only biochemical determination in studies 
involving zinc status (6,15-17). The present study was 
undertaken to examine the relationship between plasma zinc 






Sixty-six apparently healthy male adolescent volunteers 
-between the ages of 10.6 and 14.3 years from an upper middle 
income background participated in a nutritional assessment 
study in the Spring of 1988. The study was approved by the 
Internal Review Board at Oklahoma State University for 
studies involving human subjects. After explaining all 
aspects of the study to the subjects and parents, informed 
consent was obtained from both parents and subjects. 
Anthropometric Measures 
One person using a calibrated beam balance scale and 
steel tape with right angle head board weighed and measured 
all subjects in light street clothing without shoes on the 
morning of blood collection. Triplicate triceps skinfolds 
using Lange calipers (Cambridge Scientific Instruments, 
Cambridge, MO) and midarm circumference were measured on the 
right arm by another individual. These measurements were 
compared with national norms from NHANES-I data (18). 
Height percentiles were determined using maturation based 




Fasting venous blood was drawn using 21 gauge stainless 
steel butterfly needles {Deseret Medical, Inc., Sandy, Utah) 
and plastic syringes {Sarstedt, Numbrecht, W. Ger.). Three 
drops of 10,000 USP units/mL heparin, which was passed 
through a prepackaged chelating resin which scavenges for 
divalent ions including zinc {Chelex 100, Bio-Rad 
Industries, Richmond, CA), was the anticoagulant. Blood 
samples were kept on ice until separated no more than three 
hours after collection.' Plasma was separated by 
centrifugation at 1520 x g for 22 min at 4o c and 
immediately transferred with polyethylene transfer pipets to 
acid washed polyethylene storage tubes. Plasma for zinc and 
dehydroepiandrosterone sulfate {DHEAS) analyses was stored 
frozen. Plasma for total and high density lipoprotein {HDL) 
cholesterol was stored refrigerated until analysis within 
24 h. 
Plasma Zinc 
Plasma zinc was determined by flame atomic absorption 
spectrophotometry {FAA) using a Perkin Elmer 5100 PC Atomic 
Absorption spectrophotometer {Norwalk, CN) and a 
modification of the procedure of Rodriguez et al {20). 
Wavelength of 213.7 nm and slit of 0.7 nm were used with the 
air and acetylene flow rates set to 10.5 L/min and 1.9 L/min 
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respectively. Duplicate readings integrated over 3 s were 
used for calculations based on mean peak area. 
Samples were prepared by dilution of 400 uL plasma with 
1.6 mL of 0.5 % double distilled nitric acid (GFS Chemicals, 
Columbus, Ohio) in a laminar flow clean air hood. Water 
tested to contain <0.005 ug Zn/L was used in all steps of 
the analysis. Standards of o and 0.4 mg/L zinc were 
prepared in 30 g/L certified gylcerol in 0.5 % nitric acid. 
Glycerol, tested to contain undetectable amounts of zinc, 
was used to increase the viscosity of the standards to that 
of diluted plasma thereby eliminating a frequent problem in 
plasma analyses. Maintaining similar aspiration rates for 
both plasma and the glycerol solution provided more accurate 
results than when standards were prepared only in diluted 
acid because calculations were based on the peak area in a 
preset time period. A dilute acid solution enhanced the 
absorption signal to the photomultiplier tube. After each 
sample 0.5 % detergent (ERA, Proctor and Gamble, Cincinnati, 
OH) solution was aspirated to prevent clogging of the 
tubing, nebulizer or burner head. Water was then aspirated 
until the flame returned to normal color and appearance. 
Standards and a control sample of plasma were periodically 
reread. Corrections were made to readings to adjust for 
minor baseline drift. Care was taken throughout sample 
collection, storage and dilution to prevent environmental 
contamination. 
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Hemoglobin and Cholesterol 
Hemoglobin was determined on whole blood within three 
hours of drawing by the cyanmethemoglobin method (Sigma 
Procedure 525, Sigma Chemical co., St. Louis, MO) using 10 
uL of whole blood. Total and HDL cholesterol were 
determined enzymatically (Sigma Procedures 351 and 352-3). 
DHEAS 
Dehydroepiandrosterone sulfate (DHEAS) was used to 
assess maturation status. Duplicates of 10 uL of plasma 
were used to assay this adrenal androgen with a double 
antibody radioimmunoassay kit (Cambridge Medical 
Diagnostics, Billerica, MA). DHEAS concentrations were 
compared to reference values established for a pediatric 
population (21). 
Nutrient Intake 
Nutrient intakes were estimated from a pretested 
quantitative food frequency questionnaire. Portions were 
estimated using nonbiasing food models (22) in amounts 
ranging from 1 tsp to 2 c. Subjects were asked to recall 
food consumed for approximately four months. Data were 
converted to amounts consumed per day and were analyzed 
using the Food Processor II (ESHA Research, Salem, OR). 
Nutrient supplement data were obtained from label values and 
were included in total daily intakes. 
106 
statistical Analyses 
The results are presented as means_+ SEM. Two subjects 
whose triceps skinf olds were more than 2 SD above the mean 
and one with an unusually high plasma zinc of 20.1 umol/L 
were eliminated from these analyses. Statistical 
significance was defined as p<0.05. After preliminary 
calculations of correlation coefficients, analysis of 
variance was calculated for predetermined groups with the 
General Linear Models for unbalanced groups using version 
5.18 of the Statistical Analysis System (SAS Institute, 
Inc., Cary, NC). 
Results 
Mean plasma zinc was 13.8 umol/L (900 ug/L) and ranged 
from 9.7 to 17.1 umol/L (633 to 1119 ug/L). Plasma zinc was 
not correlated with any of the anthropometric or biochemical 
measures in this study. 
There was no relationship between plasma zinc and total 
intake of zinc. When subjects were grouped by zinc intake 
no differences were found in any of the anthropometric or 
biochemical measures associated with growth and maturation 
(Table 1). This sample was generally well-nourished; only 
eight of the subjects reported food intakes resulting in 
calculated zinc intakes of <10 mg Zn/d. Even for those 
eight subjects, neither growth, maturation, nor plasma zinc 
appeared to be affected. Calculated protein intakes were 
significantly lower in the low intake group than in those 
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consuming more zinc, but the calculated protein intake still 
exceeded the Recommended Dietary Allowances (RDA) for 
adolescent males (23). Mean reported nutrient intakes for 
certain nutrients which have been shown to affect zinc 
absorption or utilization are shown in Table 2. Mean 
nutrient intakes for all subjects met or exceeded the 
RDA (23). 
Because severe zinc deprivation affects growth 
resulting in nutritional dwarfism, the subjects were 
categorized by growth achievement (Table 3). Subjects who 
had achieved the 25th height centile or less were grouped as 
short and those with greater height achievement were grouped 
as average. Highly significant differences were seen 
between these groups for height, weight and MAMA. 
Significant differences also existed between the groups for 
body mass index (W/82) and DHEAS. However, there were no 
differences in plasma zinc, hemoglobin or cholesterol. 
Neither dietary intakes of protein nor zinc were 
significantly different. 
Subjects were then grouped by tertiles of plasma zinc 
(Table 4). None of the anthropometric or maturation-based 
biochemical variables were significantly different based on 
plasma zinc concentration. Significant differences were 
found in total plasma cholesterol among the lowest and 
highest tertiles while no differences were seen between the 
middle and either the lowest or highest tertile groups. 
These same groups had significant differences in dietary 
zinc intakes, but there was no correlation between total 
zinc intake and cholesterol concentration. 
There were siqnif icant differences in calculated 
protein and zinc intakes between the lowest and hiqhest 
plasma zinc qroups. No significant dietary differences 
existed between the lower two tertiles. Even thouqh the 
lowest tertile of plasma zinc reported consumption of 
significantly less dietary zinc than the hiqhest tertile, 
the mean amount was above the RDA for adolescent males. 
Discussion 
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Zinc is known to be necessary for qrowth and 
maturation. Plasma zinc concentrations were not related to 
calculated nutrient intakes, to maturation or to growth 
variables in this study of 10.6 to 14.3 year old adolescent 
males. There was no siqnificant relationship between total 
zinc intake and plasma zinc levels. In addition, height, 
weiqht, MAMA, and hemoglobin known from previous analyses to 
be related to qrowth and maturation were not siqnif icantly 
different based on total zinc intake. The mean intake of 
zinc in this sample was above the RDA for adolescents; these 
subjects appeared to be adequately nourished based on qrowth 
achievement. 
Supplements of iron and f olacin have both been related 
to inhibition of utilization of zinc (24-28). Those 
subjects takinq nutrient supplements did not take larqe 
doses of single nutrients; nutrient ratios did not approach 
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those suggested to affect zinc status (25,26,28). No 
relationships were found between these dietary factors and 
plasma zinc, growth or maturation. 
While Butrimovitz and Purdy (16) found a second degree 
polynomial relationship in plasma zinc in males their age 
span was wide - infants to age 18. They also reported 
decreasing plasma zinc from a peak of about 12.9 y until 
approximately 16 when concentrations again rose. Their 
subjects were non-fasting, and time of blood drawing was not 
controlled; thus, comparisons are difficult, because plasma 
zinc decreases during the day and after food consumption 
( 30) . 
Pilch and Senti (30) also reported lower serum zinc 
during adolescence than occurred in older subjects from 
analyses of NHANES-II data. Their data grouped subjects 
from 9-19 y in one adolescent group; none were fasting. At 
all percentile rankings adolescent values for plasma zinc 
were higher than those in the younger males aged 3 - 8 
years. In the studies of Butrimovitz and Purdy (16) and 
Pilch and Senti (30) data were analyzed comparing plasma 
(serum) zinc levels to height. One found a second degree 
polynomial relationship between plasma zinc and growth index 
plotted against age (16) while no relationship was found 
between height and plasma zinc in the NHANES-II data (30). 
In both of these studies subjects ages were in wider groups 
than were in our sample. In our sample, as in the NHANES-II 
sample, there was no relationship between plasma zinc 
concentration and any of the measures of growth. 
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Severe zinc deficiency in the Middle East resulted in 
marked growth and maturation retardation; those diets were 
known to be low in animal protein and high in dietary fiber 
(2-4). Our subjects consumed adequate amounts of protein. 
Meat consumption was reported daily. Even in our group with 
low growth achievement mean dietary protein and zinc intakes 
were adequate (Table 3). 
In adolescent males Wagner et al. (15) reported 
increases in serum zinc only for those with the adult sexual 
maturity rating; the plasma zinc concentrations in Tanner 
stages 1 - 4 were similar but were significantly different 
from mean concentration in Tanner stage 5. Variables 
identified as related to sexual maturation in our study 
included increased height, increased muscle mass, and 
increased hemoglobin concentration. DHEAS was used as a 
marker of maturation. 
plasma zinc and DHEAS. 
No relationship was found between 
It was unlikely that we had subjects 
in adult sexual maturation stages, however, as the oldest 
subject was 14.3 y; the age range in our study was 
deliberately narrow to detect small differences during 
growth years. Because Babalola and Ellis (21) found widely 
overlapping values between Tanner stages particularly in 
stages four and five and wide ranges of normal adult male 
concentrations, it was difficult to determine if any of our 
subjects had achieved adult sexual maturation. 
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Experimental studies have investigated plasma zinc 
levels in different stages of restriction. Baer and King 
(31) found that plasma zinc fell less rapidly than did 
urinary zinc and declined to <10.7 umol/100 g (70 ug/100 g) 
only after urinary zinc declined to <2.4 umol/d (150 ug/d). 
After seven weeks on a diet restricted to 5.5 mg Zn/d Wada 
et al (32) found mean serum zinc declined only 0.9 umol/L 
which was insignificant. Rabbani et al. (33) reported that 
plasma zinc fell more slowly than did lymphocyte zinc during 
depletion; lymphocyte zinc declined significantly after 
eight weeks of depletion. Plasma zinc declined and 
increased with depletion and repletion, but the differences 
between baseline, depletion, and repletion were not 
significant. The mean zinc content of the depletion diets 
was 4.8 mg/d. Thus, in our subjects with relatively high 
reported mean zinc intakes, the lack of low plasma zinc 
concentrations seems reasonable. 
Blood is an easily accessible body tissue. Ease of 
access does not suggest that all components will be equally 
useful in monitoring nutritional status. The present study 
found relationships between easily determined anthropometric 
variables and maturation, but these were not related to the 
plasma zinc level. Zinc nutrition is important in the 
maturation process and should be assessed in populations 
during growth years. From NHANES-II data Pilch and Senti 
(30) estimated that the occurrence of low plasma zinc levels 
was about 1% in the 9-19 y male age group. Low plasma zinc 
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was defined as less than 70 ug/dL (10.71 umol/L). They 
expressed concern that the concentration defined as low has 
been arbitrarily used in other published reports. If <70 
ug/dL as the definition of low plasma zinc is accepted, only 
two of our subjects met the criteria. These occurrences of 
low plasma zinc are actually more than would be expected if 
the incidence were 1% of the adolescent population. Neither 
of these adolescents was short nor had low plasma DHEAS 
concentrations. 
Further, Abdulla (34) stated that 98 % of the body zinc 
was intracellular and that plasma zinc may only be a 
transport medium. If plasma contains only 2 % of the body 
zinc, the lack of association between plasma zinc and growth 
and maturation seemed rational. Abdulla also stated that 
clinical signs of zinc deficiency were generally not seen 
until plasma zinc was <0.6 mg/L (9.1 umol/L). None of our 
subjects had plasma concentrations <9.7 umol/L. 
It is possible that during maturation zinc deficiency 
must be severe and coupled with other physiological stresses 
before plasma zinc is affected. Those severely affected in 
the Middle East consumed diets low in animal protein, 
practiced geophagia, and had high fiber intakes with few 
fresh fruits and vegetables. None of our subjects reported 
such restricted food intakes, and none acknowledged 
geophagia. 
Based on national estimates of potential low plasma 
zinc concentrations and the lack of relationships to 
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anthropometric and maturation measures, plasma zinc does not 
appear to be a useful measure of zinc status for nutritional 
surveys of healthy adolescent males. There may not be a 
"single" indicator for zinc status; concentrations of zinc 
in other relatively accessible tissues such as erythrocytes 
and various white blood cells as well as zinc dependent 
enzymes should be investigated for relationships to growth 
and maturation. Perhaps the survey assessment tool for zinc 




Plasma zinc growth and maturation measures by zinc 
consumption! 
Variables <10 mg Zn/d 
n=8 
Age, y 13.1±0-2 
Height, cm 157.9±2.0 
Weight, kg 48.3±3.8 
W/S2 19.3+1.2 
MAMA, cm2 33.4±2.0 
Hemoglobin, g/L 140.4±3.5 
Cholesterol, mmol/L 3.89±0.15 
HDL, mmol/L 1.20±0.04 
DHEAS, umol/L 5.6±0.8 
Plasma zinc, umol/L 13.4±0.7 
Dietary protein, g 3 57+13a 
Dietary zinc, mg 3 8+3a 




























1 Row means with different superscripts are significantly 
different 





































Plasma zinc, dierary protein and zinc, growth and maturation 
by height groups 
variable 
Age, y 
Height, cm 3 
Weight, kg 4 
W/S2 5 





Plasma zinc, umol/L 
Dietary protein, g 






37. 9±1. 2 a 
17.1±0.3 a 























1 Row means with different superscripts are significantly 
different 





























Cholesterol, mmol/L 23.61±0.13a 
HDL, mmol/L 1.21±0.03 
Plasma zinc, umol/L 2 312.l+O. a 
Dietary protein, g4 100±9a 
Dietary zinc, mg4 16±2a 




































1 Row means with different superscripts are significantly 
different 
2 p<0.05 3 p<0.0001 4 p<0.02 
b 
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CHAPTER VI 
SUMMARY AND CONCLUSIONS 
Summary 
Sixty-six white adolescent males between 10.6 and 14.3 
years were assessed for growth, dehydroepiandrosterone 
sulfate (DHEAS), and plasma zinc in the Spring of 1988. The 
study was approved by the Internal Review Board at Oklahoma 
State University, and informed consent was obtained from 
each subject and at least one parent. Subjects were 
interviewed for health background, use of medications and 
nutrient supplements and frequency of food consumption. 
Each subject was weighed and measured for height, arm 
circumference and triceps skinf old on the day that fasting 
blood samples were drawn. 
Significant differences among groups were found for 
height, weight, and mid-arm muscle area (MAMA) when subjects 
were grouped by age. The differences were not found between 
the same age groups for all measurements. 
When subjects were grouped by DHEAS categories, 
significant differences existed between the lowest group and 
the two higher groups for height, weight, body mass index 
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(W/s2), MAMA and hemoglobin concentration. All of the 
increased anthropometric measurements and the increased 
hemoglobin concentration are characteristics of 
physiological maturation and support the use of DHEAS as a 
marker for maturation in adolescent males. 
Plasma zinc concentration was not significantly related 
to age, DHEAS concentration, or to dietary intakes of 
protein or zinc. Except for two subjects all had plasma 
zinc concentrations within the commonly accepted normal 
range. The lack of association of plasma zinc with any of 
the maturation or growth measures or with dietary zinc 
suggests that in apparently healthy adolescent males, plasma 
zinc may not be a good indicator of zinc status. 
Conclusions 
The objectives of the study included assessing 
adolescent males for growth, maturation and plasma zinc as 
parts of nutritional status evaluation. Based on the 
results of these analyses the following· conclusions were 
reached. 
Hypothesis One 
There will be no statistically significant differences 
by ages in nutritional status measures among healthy male 
adolescents. 
Hypothesis one was rejected. These subjects as 
evidenced by growth and estimated nutrient intake were 
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healthy. Differences in anthropometric measurements existed 
between age groups for height, weight and midarm muscle 
area. These differences in anthropometric measurements were 
not correlated to nutrient intakes and did not occur between 
the same age groups for all measurements. There were no 
differences in estimated nutrient intakes when the 
adolescents were grouped by age. 
Hypothesis Two 
There will be no statistically significant differences 
in growth measures relative to maturation status among 
healthy male adolescents. 
Hypothesis two was rejected. Significant differences 
were found among the maturation categories for height, 
weight, body mass index (W/S2) and midarm muscle area 
(MAMA). The differences were between the group with the 
lowest DHEAS concentration and the two higher groups. There 
were no significant differences in growth measures between 
the two higher DHEAS concentration groups. 
Hypothesis Three 
There will be no statistically significant difference 
in plasma zinc concentration based on maturation. 
Hypothesis three was not rejected. No significant 
differences were found among DHEAS groups or by plasma zinc 
concentration. There was no significant relationship 
between plasma zinc and any of the measures associated with 




There will be no statistically significant difference 
in plasma lipids based on maturation. 
Hypothesis four was not rejected for total cholesterol. 
Differences were found between DHEAS group I and groups II 
and III but these differences did not reach the significance 
level of 0.05. HDL cholesterol differences existed between 
DHEAS group II and III. The highest DHEAS concentration 
group had a significantly greater concentration of HDL 
cholesterol than did the middle group. Therefore, H4 was 
rejected for HDL cholesterol. 
Hypothesis Five 
There will be no statistically significant relationship 
between dietary zinc and measures of plasma zinc, growth, 
maturation and plasma lipids. 
Hypothesis five was not rejected. Dietary zinc was not 
correlated to height, weight, W/S2 , MAMA, hemoglobin, DHEAS, 
plasma zinc or total and HDL cholesterol. While zinc is 
known to be essential for growth and maturation, all except 
eight subjects reported an estimated food consumption 
providing more than two-thirds of the RDA for zinc. They 
reported consumption of greater quantities of protein than 
estimated to be needed for growth and much of this protein 
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was of high quality. Therefore, these subjects consumed 
zinc with probable high bioavailability. There were 
insufficient numbers of subjects with reported low zinc 
intakes or zinc intakes low enough to apparently affect 
growth and maturation. In addition, nutrients reported to 
decrease zinc absorption, namely high intakes of fiber, 
folacin and iron, were not consumed in unbalanced ratios. 
Therefore, it was concluded that these subjects consumed 
adequate levels of zinc and other nutrients for adequate 
rates of growth and maturation. 
Adolescent males grow and develop at different ages and 
at different rates. The fact that only some differences 
were seen by ages for anthropometric measures is a clear 
illustration of this commonly acknowledged information. 
When subjects were grouped by concentrations of an adrenal 
androgenic hormone (DHEAS), the differences in growth rates 
were apparent. By DHEAS groups no significant differences 
existed for age, but the measures of growth (height, weight, 
W/s2 , and MAMA) were significantly different. Thus, DHEAS 
was useful in distinguishing those adolescents either who 
had not entered puberty or were in very early stages (Group 
!) from those who were more mature (Groups II and III). The 
subjects were intentionally limited in age range in order to 
provide groups for studying maturation, and the changes 
associated with it. However, if these adolescents were 
observed over time, significant differences might appear in 
other measures as maturity approaches. 
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The sample for this study was primarily from upper 
middle income families. outwardly, they all appeared 
healthy. The mean nutrient intakes met or exceeded the RDA 
for all nutrients investigated. The fact that plasma zinc 
did not correlate with any of the anthropometric or 
biochemical measures suggests several possibilities. These 
boys may have all been well enough nourished to have plamsa 
zinc concentrations within normal limits. There was no 
justification for concluding that zinc malnutrition existed 
in this sample; however, due to the wide ranges of normal 
plasma zinc concentration, one cannot state that some of 
these males were not in marginal zinc status. If any were 
marginally deficient in zinc, apparently this deficiency was 
not great enough to affect growth in ways identified by 
usual anthropometric measurements. Thus, the question of 
zinc status still exists for these adolescents. 
Longitudinal data from these subjects might provide some of 
the answers. Zinc supplementation studies in similar males 
might also provide needed information on the usefulness of 
plasma zinc as a measure of zinc status during adolescence. 
Other physiological changes that occur during 
maturation include changes in cholesterol and hemoglobin 
concentrations. Had other measures of iron status been 
included, one could better relate low hemoglobin to 
immaturity and not to iron deficiency. Nevertheless, the 
increases in hemoglobin concentration paralleled the changes 
in DHEAS concentration. Estimated dietary intake data 
supported adequacy of iron consumption which also lends 
support to the maturation-hemoglobin relationship. 
Nevertheless, additional measures of iron status would 
clarify the maturation-hemoglobin relationship. 
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While statistically significant differences were not 
found in plasma cholesterol by either age or maturation 
groups, trends for decreasing concentrations for total 
cholesterol wer·e apparent by age group. The food frequency 
questionnaire was not designed to identify sources of fat in 
the diet other than that contained in dairy products and 
meats. Therefore, no analyses could be done on the dietary 
fat-cholesterol relationships in these adolescents. None of 
these subjects had extremely elevated cholesterol 
concentrations, and family history of cardiovascular disease 
was not assessed. Based on the data collected one can only 
conclude that the means were within normal ranges and that 
decreases in cholesterol concentration with age were not 
clearly identified within the maturation limits of this 
study. The important relationship between changes in 
cholesterol concentration over time awaits further studies. 
The lack of significant relationships between total 
zinc intake and growth, maturation, plasma zinc and plasma 
lipids was not a surprising finding. If dietary intakes 
were sufficient to allow adequate growth, then the 
differences between adequate growth and optimal cellular 
function would be difficult to measure. Only eight of the 
subjects reported estimated consumption of less than two-
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thirds of the RDA for zinc. Two-thirds of the RDA is an 
arbitrary, but commonly used, limit. Based on the RDA the 
need for zinc is estimated to be 6 mg/d in preadolescent 
children and also 6 mg/d in adults. No estimates of need 
have been published for adolescents. If adolescents needed 
the same amount as adults or children, practically all of 
these subjects met or exceeded their requirement. 
Therefore, one would not expect to find clinical zinc 
deficiency. 
This study introduces questions which require further 
study. It does provide guidelines and comparison points for 
those studies, however.· DHEAS is relatively easy to 
measure; it did provide information on which to base 
maturation categories. Further studies could evaluate DHEAS 
concentration changes and its subsequent relationship to 
completion of maturation. 
Currently information documenting growth, maturation, 
and plasma lipid and mineral concentrations in the same 
individuals does not exist in the literature. Following the 
changes longitudinally in this group of apparently healthy 
adolescent males might provide additional insight into the 
processes surrounding growth and maturation. 
Recommendations 
The following recommendations for future research were 
developed from this study. While support for use of DHEAS 
as a marker of maturation existed in this study, further 
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research using this hormone is needed. Adolescent males 
should be followed longitudinally to determine the 
relationship between DHEAS and other measures of growth and 
maturation in individuals over time. 
Adolescent males should be evaluated during maturation 
for zinc status to determine the effect of maturation on 
plasma zinc and other measures of zinc status in 
individuals. Several possible zinc status measures 
including blood cells and zinc dependent enzymes need to be 
evaluated in adolescent males to determine those which are 
responsive to growth and to maturation changes for use in 
nutritional assessment studies of adolescents. 
Adolescent males need to be studied longitudinally for 
the relationship between plasma cholesterol, other blood 
lipids and growth and maturation. Repeated measures over 
time related to changes in maturation may be useful in 
identifying characteristics of cardiovascular risk present 
in youth. Those characteristics so identified could lead to 
early intervention and treatment. 
Investigations on methods of assessing dietary intakes 
of adolescent males are needed. Information on the 
reliability of food frequency records for estimating mineral 
intakes needs to be collected. Comparison studies of 
nutrients estimated from food records of various lengths in 
different seasons and from food frequency records need to be 
conducted. 
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An improved nutrient data base should be sought to 
reduce the number of food items for which estimates of 
composition must be made. Data bases should be identified 
which are frequently updated with not only complete but also 
reliable information regarding nutrient composition of food. 
Males from low socioeconomic background need also to be 
studied to provide a more complete overall description of 
the nutritional status of adolescent males during rapid 
growth and maturation. 
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TANNER MATURATION STANDARDS 
141 
142 
Genital Development Stages for Males 
stage 1 - Preadolescent. Testes, scrotum and penis are 
similar in size and proportion to early childhood. 
stag~ 2 - Scrotum and testes enlarge. The skin color and 
texture of the scrotum change. There is little to 
no enlargement of the penis a this stage. 
Stage 3 - Enlargement of the penis primarily in length. 
Additional growth of testes and scrotum. 
Stage 4 - Increased size of penis primarily in breadth. 
Development of the glands. Continued enlargement 
of the scrotum and testes. Continued darkening of 
the skin of the scrotum. 
Stage 5 - Adult genitalia in size and shape. 
143 
Pubic Hair Stages 
Stage 1 - Preadolescent. No pubic hair. 
Stage 2 - Slight growth of long lightly pigmented fine hair 
appearing primarily at the base of the penis or 
along the labia. Not photographable by usual 
techniques. 
Stage 3 - Hair is much darker, coarser and more curled 
spreading over the junction of the pubes. 
Stage 4 - Hair resembles adult in type but area covered is 
less than in the adult. There is no spread to 
medial surface of the thighs. 
Stage 5 - Adult distribution and quantity of hair. Hair is 
spread to medial surf ace of the thighs but above 
the base of the inverse triangle. 
Tanner, JB. Growth at Adolescence. 2nd ed. 








Adolescent males aoes II through 13 
Human nutrition research investigating zinc status in 
males* 
WHY1 Zinc is a mineral required for growth and development, 
for ability to taste, and for heal Ing of wounds. 
There are indications that males have a greater need 
for ·zinc than females and that the need for zinc is 
great prior to the growth spurt of adolescence. This 
project will evaluate various measures of zinc status 
related to maturity and to growth. 
HOW1 Measurements include those for growth--height, weight, 
body fat stores; for usual dietary intake of zinc and 
other nutrients1 and for zinc in the blood. 
WHEN1 January and February 1988 
WHERE1 Department of Food, Nutrition, and Institution Admin. 
College of Home Economics 
Oklahoma State University 
BENEFITSr Exp er I ence In and exposure to re:.ear·ch 'cur·ren t I y being 
conducted. Reports of growth achievement, hemoglobin 
and cholesterol levels will be provided to parents of 
a 1 I part I c I pan ts, 
REWARDS& All participants will receive a movie pass, coupons for 
various restaurants and recreational activities, and 
breakfast on the day of data col I ec t I on, IN ADDI TI ON, 
all participants will be entered into a special 
drawing for one of four $25.00 gift certif lcates at a 
local sporting goods store. This drawing is for 
participants in this study only!! 
FOR FURTHER INFORMATION CONTACT1 
Andrea Arquitt, H.S., RD/LD 




watch for a letter providing more Information about 
this project coming soon. 
* This project has been reviewed and approved by the Internal 
Review Board at Oklahoma State University for research involving 






INFORMED CONSENT FORM 
for 
Participants In the Research Study 
Zinc Status of Preadolescent Maless An Evaluation of Measures 
I give permission for my son/ward---------------------- to 
participate In the above named research. I understand that he 
will participate In the following procedures• 
1. completion of a health background questionnaire; 
2. completion of a food frequency questionnaire; 
3. anthropometric measurements of height, weight, mid-arm 
circumference, and triceps fatfold thickness; and 
4. twenty mlllll lters of blood will be drawn using sterile 
techniques by~ certified Medical Technologist. 
Two questionnaires will be completed In an Interview of one hour 
or·less. The anthropometric measurements and blood collection 
will be obtained In the Department of Food, Nutrition, and 
Institutional Administration at OSU In one time period to be 
arranged. The participant should not eat after midnight the 
night preceding blood collection. 
In addition, I agree to supply background health Information 
regarding birth weight and length, history of Illnesses, and 
parental height, If known. 
I realize that this study has been reviewed and approved by the 
Internal Review Board for research Involving human subjects at 
Oklahoma State University and by a local medical doctor. 
I real lze that may withdraw my child/ward from this study at 
any time without penalty by contacting the principal investigator 
at the telephone numbers I lsted below. I also understand that 
all test results will remain confidential ant that my 
son's/ward's name will not be associated with the results. 
understand that the Department of Health and Human Services and 
the Federal Drug Administration may Inspect the records of this 
Investigation. 
I have been Informed of all procedures and I understand them. 
Principal investigators ___________________________ _ 
office telephone: 624-5039 






Subject No. ____________ _ 
Food Frequency Questionnaire 
Adol•scent Nutrition Study 
FNIA Department 
College of Home Economics 
Oklahoma State University 
Stillwater, Oklahoma 74078 
You are participating in a project designed to Identify the foods which are 
sources of zinc and fiber commonly eaten by teenagers In order to learn 
which foods are eaten I will read a I 1st of foods to you one at a time. I 
will also read some frequency of consumption categories to you: "Never, 
more than once a day, once a day, more than once a week, number of times 
last week, once a week, less than once a week, but more than once a month, 
and less than once a month." 
You will also Identify from food models the usual size of the portion that 
YOU eat. 
Do you have any questions? 
Thank you for your help. 
Before we start the actual questionnaire let us go over some examples. 
Below you will find I lsted foods which you may or may not commonly eat. 
want you to think about whether or not you ever eat that food Item. Then 
if you do eat It, please think carefully and try to estimate how often you 
•at It. Tell me the correct category as I state lt1 then you will select 
from the food models for the portion size. 
EXAMPL ES: If YOU eat beef 5 times a week mark as follows 
~ood Item Never more 1x/ more II times 1x/wk <1x/wk <1x/ Fd Mod 'Po.-M9'\ 
1x/da da 1x/wk week >Ix/mo mo Code 
?x l st 
month 
Beef 5 
If you never eat an Item for any reason, mark the "never" column beside 
th f d It d d t th t d 't e 00 em an orocee 0 e nex foo I em. 
i=ood Item Never more 1x/ more II t Imes 1x/wk <1x/wk <1x/ Fd Mod 




If you eat an Item Infrequently, but do eat it several times a year, please 
mal'k the "less than ix/month" column. 
Food Item Never more lx/ more ti t Imes IX/WK <IXl'WK UX/ t-Clfrod 
lx/da da 1x/wk week >Ix/mo mo Code 
?x I st 
month 
??? x --If you eat some of these items In food comb1nat1ons, please mark as a 
single Item. For example, If you eat tuna-rice casserole once a week, mark 
both tuna and rice In addition to the tuna and rice you may eat s•parately. 
1_48 
149 




more M times lx/wk <lx/wk 
lx/wk week >Ix/mo 
?x I st 
month 




2 3/4" IS~ 
3 1/4" '~ 









---------------- ----- ----------- -------·----- ------------ ------ ----~-Cantaloupe 
Cubes ;~3 
Me I on :a~f 
------- - - --- - -- -~--- - ------- - - -i==-======·-*-=-=-:-==-4===-~-==-=*=-===-~1 
Fruit 




---------------- ----- ----- ----- ------- ----- ------------ ------ ------Grapes 
Thomp .233 
Tokay :13~ 
---------------- ----- ----- ----- ------- ----- ------------ ------ -------
Orang• 
Nave I :lt.' 
Valencla.'7 
Aver age ,a, 13 
--------- ------ ----- ----- ----- ------- ----- ------------ ------ -------
Orange 
Juic• :m 





3 Juice J.IS 
v LI gh t :ti~ 
lx/da da lx/wk week >Ix/mo mo Code 
?x I st 
month 
--------- ------ ----------- ----- ------- ----- ·------------ ------ -------Pear 
Bart I• tt ~'f.t 
Bose J.f'I 
D'AnJou 2.,6° 
:f Heavy :1"7 
11~~~~1'~,?~~.PMt ____ ;_~~·~--.................. =="""'=-'~=="""'"""'=-===-=-~-:=,,,-=-=-~===-===...~-=<:-,,,,.,~-====-=-=-===-=-:=:=-==~ 
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Food I ttm N•ver more 1></ more It t Imes 1 )(/Wk (J)(/Wk < 1 )(/ ~d Mod Po.-h·u,. 
1)(/da da 1)(/Wk we•k >1)(/mo mo ~ode 




Fresh ] Heavy JoS' 3oc, Juice 507 'oS LI gh t JO'I ~ 10 






Raisins 330 ----------.. ----- ------ ----- ----- -------- ----- ------- t------ ~------- -----Strawberr I 1 s 
Fresh 3'" 
Frozen 351 
----------- ----- ------ ---- ----- -------· ----- -------...------ r--------- -----
Wa te rme 130.,.n'I' 
Food Item Never more Ix/ more It times lx/wk (1)(/Wk <Ix/ Fd Mod Porh'o" 




fru It not 
men t I oned? 
._ _________ ... 
----- ----- ----- ------ -------- ----- ------- t------
.,_ _______ 
~-----
- -- -- -- ---- -- - -- ----- - - - ---- -- - -- -- - - -- --- --- -- --
~--------- ----- ----- ----- ----- ------- ----- -------1------- --------------
1----------- ----- ----- ----- ----- ------- ----- ------- i------- -------- ------
i=ood Item Never more lx/ more It times lx/wk <lx/wk <lx/ Fd Mod Po.-ko., 







1----------- ------ ---- -----1------ ------- ----- ------------ -------- ------Broccol 11 ~I'~ -s 
Fresh llJ.I 
Fr oz. "J." 
- - -- - - __ , --
~abbage·&1.1c. 
_..t.~!r.:!L'L:u. ii""---- ------ -----.------ ------- ----- ------------ ------- ------arrots,..."'" 
>-----~+-!.~! 
4_ _____ 
------ ---- ..,. _____ ------ ----- ------- ~---- -------- -------Celery '-1~1 
151 
Food Ihm N•v•r nor• lx/ mor• " t lm•s Ix/wk <Ix/wk <Ix/ ,.:d Mod Po.-h'on lx/da da Ix/wk week >Ix/mo mo Code 













Sau teed l/f7 







Fr oz. ,,,~ 
Cnd 5,1 
Food I tern Never more lx/ more ti t Imes Ix/wk <Ix/wk <lx/ Fd Mod 





Flesh & c.: J< In St.3 
Flesh onl ~ S''! 
SK In on 1 > 5''° 
---------- ~-----1-------~---- ----- -------------- ------- ----- ------- _____ ..., Potatoes 
Soi .1 ed ,,. 
---------- ~-----~------ ~---- -----· ------------- ------ ----- ------- -------Potatoes 
French Fr I• !i 
Home ~1( 
Fast Fooc 1•11 
~~ ..iii~"' ZTEJ' 
.. ·--· ... -- -- ------- --- - -- ----- --- - ----- - ---- - - -- -Potatoes, 
Mashed 
Fresh S81 -
Dr led ,,2. 
---------------------------- ------ -------- ----- ------- ----- ------- -------Potato chips ______ _s~----------------- ----- ------------- ------- ----- ------ -------
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Food Item Never more Ix/ more ti t Imes Ix/wk <Ix/wk <Ix/ Fd Mod ' Porl-i•I'\ lx/da da Ix/wk week >Ix/mo mo Code i 




Fresh ckd f,o~ 






Cnd fl'I ,_ 
Food Ihm Never more lx/ more ti t Imes Ix/wk <lx/wk <lx/ Fd Mod Po.--lio., 
lx/da da Ix/wk week >Ix/mo mo Code 




not ment Io rtt'd? 
---------- ------ ----- ------ ----- -------- ----- ------- ----- ------- ----
--------- ------ ----- ------ ----- ------- ------------- ----- ------- -----
----------
,,_ ______ 
----- ------ ----- --------------------- ------------ ------
--------1------ ----- ------ ----- -------- ------..------ ----- ~------ ------
----------------- ----- ------ ----- -------- ------ ------- ----- i--------- ------
Food Item Never more lx/ more ti t Imes lx/wk <lx/wk <lx/ l=d Mod Po .. ~o., 
lx/da da Ix/wk week )Ix/mo mo Code 
?x I st 
month 
Cheeses, 
ye I low 





----- ------ ~---- -------- ~----- f-------- _..:, ___ ------- ------
Cheeses, 
Wh I te 
Mont•rey Jacku~o 
Mozzarel I a o~J. -
Swl SS ol/-B 
r----------1------- ----- ------i------ --------1------.,_ ______ ----- ------- ------Cottage 014 
Che•se 
1----------1------- ----- ----------- -------------- ------- ----- ------- ------Cocoa OI" 
)53 
~ood Ihm Nev•r more Ix/ more It t lmet> Ix/wk <Ix/wk <Ix/ Fd Mod Porha., 
lx/da da Ix/wk week >Ix/mo mo Code 
?x !st 
month 






---------- ----· ----- ----- ------------ ---- ------- ----- ------ --------Yogurt 
Plain ,,, 







---------- ----- ----- ---- ----- ------- ----- ------ ----- ------ --------Ice cream 
/30 
Food Item Never more Ix/ more It t Imes Ix/wk <Ix/wk (Ix/ Fd Mod Po~·o .. 
lx/da da Ix/wk week >lx/mo mo Code 
?x I st 
month 
Almonds 




IS"S"1 ---------- ---- ---- ---- ------ ------- ----- ------ ----- ------ -------Peanut 
But te~S'~O 
Pecans If"'! 
--------------- ----- ---- ------ ------- ----- ----- ------ ------ --------Sunf I ower .• 
C:a~de /$"8) 
Tofu "3B ---------- ----- -----· ---- ----- ------- ----- ------ ----- ------ --------Baked 
Beans_!!.L ----· ----- ---- ------ ~----- ----- ------ ----- ------ --------
Food Item N•ver more Ix/ more tt times Ix/wk <Ix/wk (Jx/ Fd Mod PorHa" 
lx/da da Ix/wk week >Ix/mo mo Code 
?x I st 
month 













more M times Ix/wk <lx/wk 
Ix/wk week >Ix/mo 
?x I st 
month 
<Ix/ Fd Mod 
mo Code 
______ .l)J!______ ----- ----------- ------- ----- ------ ----- ------ -------
Pork I I 
Chops BHi ! 
-~~~~~!.:!J ______ ~----- ----------- ------- ----- ------ ----- ------ -------
H am v~~ I 
Sausagt. .,,,_ ---------------- ----- ----- ----- ------ ----- ------· ----- ------ -------Luncheon 
meats 
Bologna 'f • .J 
pepperon I ""' 











Drumst Id l'•t.. 
Ix/ 
da 
more M times Ix/wk 
Ix/wk week 
------ ----- --------------





<Ix/ Fd Mod Po..+.on 
mo Code 
__________ ,_ ___ ---- -------- ------ ----- -----·----·--------------
Turkey 





----------~-----·----- ----------- ------------- ------ ----- ------ -------Fish 
St I cks ?I/ 
Tuna 
----------~----- ---------------- ------- ----- ------Shr Imp '77/ 
other 
fish 
---------------- ----- ----------- -------
------------- ---- ---------- -------
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Food Ihm Never more lx/ more .. t Imes Ix/wk <Jx/wk <lx/ Fd Mod Po--~io" 
lx/da da lx/wk week >Ix/mo mo Code 
?x I st 
month 
Bagel "l7S" -----· - --·· - --· -··-· --·- -- ····--- -·--
Corn 
Br-ead 1 ot:s· 
-
Dinner-
Roi I /o3/ -·- -· ---·-·· 
French 
Bread 'in .. - -- - -·-
Hamburger /c :n 
Hot dog IO .,,.. 
Bun 
Food Item Never more Ix/ more .. t Imes Ix/wk <Ix/wk <Ix/ Fd Mod Por+iot1 
lx/da da lx/wk week >Ix/mo mo Code 
?x I st 
month 
Wh I te, 
1002 SI Iced ·-- ---· -- ·- --· -- .. -·-·-··---- ------- ----
1010 
WW SI iced 
-==U!~~.tl -~ -- - . -- ··-· ·--·-· ·- - ·---- ·----- .. - - ·---· .. ··- ··- . ···- ... --·- ·- ------··· --
Graham 101.1 
Crackers +----·-1-----· -··-··------- ----------·-·--·- - -----·-- ----- --
to? 
Saltines 
----. . ----- •.... ···-- .. ····- ·:..:.·~=-.;· - -
Bran 109:. 
Muffins -----··--- -·---- ----- ---·- ---------- -·------'----- -------- ---- ---
Corn Iott' 
Muffins - -------- - - -- ---




---------------- ----- ----- ------ ------- ----- ------- ----- ------ --------
-------------- ----- ----- ------· ------- ----- ------- ----- ------ --------
----------- ----- ----- ---- ------ ------- ----- ------- ----- ------ --------
Food Item Never more Ix/ more .. t Imes lx/wk <Ix/wk <lx/ Fd Mod 'Po..-ho" 
lx/da da lx/wk week >Ix/mo mo Code 
?x I st 
month 
Macaroni _______ .J.A9.o. ---- --- ---- ---- ---·---- ·------
Noodl es 11&) 
!56 
Food Item Never more 1x/ more I " t i mes 1x/wk <Ix/wk <Ix/ Fd Mod Po.-h.W. 
lx/da da lx/wk We•k >Ix/mo mo Code 
?x 1st 
I wnon th 
Spaghetti _____ J _______ 
------1~1! ----- ------ ----- ------ ------ ---- ------ ------
Pancakes ------t-----· ______ .Jl'l'!.. ------ -----· ----- ----- ----- ----- ------ ------Popcorn 9 l:JB 
Rice I Whlh 
Regular 1~1 7 I 
Instant 1~.1 
---------- ------ ------ ----- ------ ------· ------ ------ ----- ------ ------. Rice 
Brown tJ.<-r 
WI 1 d 1:1n 
Food Ihm Never more Ix/ more It t lm•s 1x/wk <Ix/wk <Ix/ Fd Mod Po.-i-to .. 




' Sht 11 /I'(/ 
---------- ----- -----· ----- ------ -------· ----- ------ ----- ------ -----Tort 111 a 
Corn 11'1'1 
Fl our 11<1r. 
- - - - - -- - -- --- -· - - - - -- ----- --- -Wafflts 
_____ Jli~- ---- ---· ----- ------ ------ ----- ------ ----- ------ -----
Brewers 
Y•ast 1?18 
"" -=--:c!:m:ilt!le Other 
Br•ads 
-------- ----- ------ ---------- ,__ ______ ----- ----- ----- ----- -----
---------- ----- ------ ----- ------ ------- ----- ------ ----- ------ -----
Food J t.m Ntv•r mor• 1x/ more It t Imes Ix/wk <Ix/wk <Ix/ Fd Mod p ... +.o .. 





Burr I to _____ .L1!L --- ---- ---- ------ ------- ----- ------ ----- ------ -----Chi I I/Bean -
- --- (}J$ 
Hamburger 
Reg/bun S" 
-----1~1-- ----- ----· ----· ------ ------ ----- ------· ----- ------ -----Hamburger 
1/4 w/bun ______ .J..}_?J ----- ----- ---- ------ ------- ----- ------ ----- ------ -----Cheeseburg r 
/bun-reg 1 ~(,Q 
Food J hm Never more 
h/d« 
Cheeseburg1 r 








?x I st 
month 
<Ix/ Fd Hod Portion 
mo Code 
---------- ----------- -----~----- ------- ----- ------------ ------ -------Hacaron I/ 
cheese 
homema.de 
_______ !.!~~ ------ ----- ---- ... ----- ------- -----




Food J tern Ix/ more 
da lx/wk 
# times Ix/wk <Ix/wk <Ix/ Fd Hod Portion 









------------ -------------------------- ------ ------------------- ------ -------
•·-----~---------o+-.._......i~--_,,. ...... __ =ru ........... ...,..., ____ F-u ..... -.~r~..-..==-~·- ---
Refried 
Beans 311 ---------- ---- ------ ----- ~-----
Spag. Set 




meat--=----=-- --=-=- = ·-·==t=--====r===="t'===r==•=--·=·-=-=-=-=-==i=-=-=-=-=-=-"'f-"-=-=-=-=-=-=-
Beet 13 i>O 
Taco ciUtc. " / 
-------- ----- ----- -----t------- ------- ----- ------ --------------------
Breakfast cereals contain a variety of nutrients and may vary considerabll 
due to dlffer•nt fortification practices. In tht next section please name 
ALL of th• breakfast cereals you eat and give tht frequency of consumption. 
Food J ttm 





more H times Ix/wk <Ix/wk 
lx/wk week >Ix/mo 
?x I st 
month 
< 1 x/ Fd Hod Portlon 
mo Code 
--------------- ----- -----1--------------- ----- ------ ------------------------------------ ------------------------------- ------ -------------------------- ------------------------------------ ---------------- ------------- ------ --------------------
---------------- --'"""".--------1--------------------- ------ --------------------
Cook•d CerEals 
---------------- ----------------- ------------------------------------ ----------------- ------------- ------t---------------
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HEALTH INFORMATION QUESTiffi~~AIRE 
Adolescent Nutrition Survey 
FNIA Department 
OKiahoma State Uni<1er·:.ity 
Health History: Subject 
Birth date: ______ _ 
Birth length: _____ _ 
Birth t'-'e i gh t =--,,-,..,----
Race: W_B __ Other ______ _ 
Subj.:-c t r.Jo. ------
Do you have or have you ever had any of the following: 
Inherited disea.se No Yes Specify 
Uremia No Yes ~;pee i fy 
Si cKl e ce 11 anemia (or sickle ce 1 l tr a i t H·Jo '(es 
Ne op 1 ast i c disease No Ye·:. 
Diabetes No y·es 
Liver diseases Ne• '(es Specif>' 
Are you on any type of special diet: 
Food allergie:.? No '{e-;. Spec i fy 
Weight loss? No Yes Spec if.~' 
We i gh t ga i n? No Ye:. Speci f> 
Other? <Specify) ____________ _ 
Have you recently had any of the following: 
Serious i 11 ness No Yes ~;pee if>' 
Surgery No y·e::. 
Fractured bones t·Jo Ye:. Spec i f y 
Dermatitis or skin rash No Ye: Di a.gnosed? 
Weight gain No \e=· HO•.'J much? 




Do you currentl >' use an>' drugs or medications?---------------
Do you take any nutrient supplements? No '(es Specify:--------
8r· and---------
Number per· day ______ _ 
Have you ever been treated for anemia? No Yes l.<.lhen? ________ _ 
How long were you treated? 
Was your b I ood re t es. t ed a f_-t,.._ e-r--:t-r-·e_o< __ """t_m_e_r_o t,..._..,.,,:-______ _ 
l.Jas the treatment considered successfu I?··-------





I'm really not interested in eating 
Do you ever eat or cra0e substances not usually considered as food? 























Mother• s barefoot height---------
Father's barefooe height 
Mother's occupation ___________ _ 
Father's occupation ___________ _ 
APPENDIX D 






Subjects were weighed to the nearest quarter pound on a 
previously calibrated double beam balance scale in light 
street clothing. 
1. To calibrate the scale six labeled concrete blocks were 
weighed individually and in planned combinations. 
2. Total weights were compared with the sum of the weights 
of the individual blocks. 
Height Measurement 
Subjects were measured to the nearest sixteenth of an 
inch standing in street clothing without shoes. 
1. Subjects stood with calves, hips, shoulders, and the 
back of the head against a surf ace perpendicular to the 
floor to which a steel tape was affixed. 
2. With the subjects looking straight ahead, a right angle 
. head board was brought down against the perpendicular 
surface to the top of the subjects head. 
3. Height was read at the point at which the head board 
met the top of the subjects head. 
Mid Arm Circumference 
1. Stand subject erect with the right arm bent at the 
·elbow. 
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2. Using a non-woven tape the midpoint of the upper arm 
was marked by measuring the length between the tip of 
the acromial process of the scapula and the oleocranon 
process of the ulna. 
3. The midpoint was marked with a small dot using a felt 
tipped pen. 
4. Using an "Insert-a-Tape" (Ross Labs) and without 
compressing the soft tissue, the mid arm circumference 
is measured at the midpoint dot to the nearest 0.1 cm. 
Triceps Skinfold Thickness 
1. With the subjects right arm hanging at the side, a 
lengthwise fold of both skin and fat was grasped 
approximately one inch above the mid arm dot. 
2. Using Lange calipers which were held parallel to the 
floor, the skinfold was measured at the midpoint mark 
by releasing the caliper onto the skinfold. 
3. Three measurements were averaged completely releasing 
the skin between measurements. 
Mid Arm Muscle Area Calculation 
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APPENDIX E 
PROCEDURES FOR BIOCHEMICAL 
DETERMINATIONS 
164 
Cyanmethemoglobin Method for Hemoglobin concentration 
(Sigma Procedure 525, revised 1984) 
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1. Reconstitute Drabkin's reagent with 1000 mL deionized 
water; store in amber glass in the dark at room 
temperature. 
2. Prepare cyanmethemoglobin standard solution by 
reconstitqting Hemoglobin standard with 50 mL Drabkin's 
reagent. Mix well and let stand at least 30 min. 
Store refrigerated protected from light. 
3. Prepare standards to provide concentrations of O, 6, 
12, and 18 g/dL as follows by mixing appropriate 
quantities of Drabkin's reagent and the 
cyanmethemoglobin standard. Store tightly capped 
refrigerated protected from the light. 
4. Label duplicate tubes for each subject. 
5. Pipet 2.5 mL Drabkin's reagent into each tube. 
6. Carefully pipet 10 uL whole blood into each appropriate 
tube. Rinse the pipet tip in the tube to remove all 
blood. 
7. Mix well and let stand at least 15 minutes at room 
temperature. Color is stable for several hours. 
8. Read absorbance at 540 nm. 
Total Cholesterol 
(Sigma Procedure 351, 1085) 
1. Prepare cholesterol reagent according to label 
directions. Mix by gentle inversion. Store 
refrigerated. 
2. Date all reagents as each is reconstituted. 
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3. Prepare fresh or pool prepared cholesterol assay 
solution in sufficient amounts to complete all tests. 
4. Duplicate blanks and standards must be read with all 
samples. 
5. Prepare tubes for duplicate determinations for all 
samples. 
6. Pipet 0.01 mL deionized water into each tube labeled 
"Blank," and 0.01 mL cholesterol aqueous standard (200 
mg/dL) into each tube labeled "standard." 
7. Pipet 0.01 plasma into each appropriate sample tube. 
8. Pipet 1.0 mL Cholesterol Assay Solution into all tubes. 
9. Incubate 10 min in a 37° C water bath. 
10. Read and record absorbance at 500 nm. Complete all 
readings within 30 minutes. 
HDL Cholesterol 
(Sigma Procedure 352-3, 1987) 
1. Prepare cholesterol assay solution as for total 
cholesterol. 
2. Prepare HDL cholesterol reagent according to label 
directions. 
3. ·Label tubes for controls and samples. 
4. Separate HDL fraction by: 
a. pipet 500 uL plasma into small tube 
b. add 50 uL HDL cholesterol reagent 
c. vortex 
d. allow to stand at room temperature for 5 min 
e. mix briefly by vortexing 
f. centrifuge all tubes for 10 min at 2200 x g. 
5. Pipet 1 mL cholesterol assay solution into fresh 
subject tubes. 
6. Pipet 50 uL water (bland), calibrator (50 mg/dL), or 
supernatant from step 4 into each tube. 
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7. Mix by inversion. Incubate tubes for 10 min at 37° c. 
8. Read absorbance at 500 nm using the blank and 
calibrator for the standard curve. 
9. Complete all readings within 30 min. 
Dehydroepiandrosterone Sulfate Radioimmunoassay 
(Cambridge Medical Diagnostics, Feb., 1987) 
1. Prepare work surface in a manner suitable for 
radioactive isotopes. 
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2. Use appropriate precautions in handling all materials 
and waste. 
3. Reconstitute reagents according to directions and store 
as instructed. 
4. Careful pipeting is essential for optimal results. 
5. Run samples and standards in duplicate; a standard 
curve must be run with each set of samples. 
Assay Procedures 
1. Label glass or polystyrene tubes as follows: 
1 - 2 Total Counts (TC) 
3 - 4 Non-specific binding (NSB) 
5 - 6 Maximum binding (B0 ) 
7 - 20 Standards B - H 
21 on Samples 
2. Pipet 10 uL DHEAS zero to tubes 3 - 6, 
3. Pipet 1 mL assay buffer to tubes 3 - 4. 
4. Pipet 10 uL of standards or sample plasma to the 
appropriate tubes. 
5. Pipet 100 uL 125r to all tubes 
6. Shake the rack of tubes gently. 
7. Pipet lmL DHEAS antiserum to all tubes except 1 - 4. 
169 
8. Vortex tubes and incubate for 30 min at 37°c. 
9. Pipet 200 uL goat-anti-rabbit gamma globulin to all 
tube except 1 & 2. 
10. Vortex and incubate for 30 min at 37°c. 
11. Centrifuge at 1500 - 1600 x g for 15 min at 2 - 8 °c. 
12. Immediately decant the supernatant except for tube 
1 & 2 (Total Counts) into a suitable radioactive waste 
jar. Pour off smoothly to avoid disturbing the pellet. 
13. Blot the rim of each tub on absorbant paper as the 
decanting is completed without returning the tube first 
to an upright position. 
14. Cap tubes. Count radioactivity in all tubes for two 
minutes. 
15. Calculation of results may be done by computer programs 
designed for semi-log data. 
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